data_2kcc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.706 0.289 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.415 HG11 ' CD2' ' A' ' 33' ' ' TYR . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.4 p . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.416 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 111.249 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.421 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 35' ' ' GLU . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.664 0.269 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.547 0.213 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.425 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.402 ' CG1' ' CD2' ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.446 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.67 0.271 . . . . 0.0 111.373 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.504 0.193 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 33' ' ' TYR . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.423 ' CG ' ' N ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.423 ' N ' ' CG ' ' A' ' 41' ' ' MET . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.7 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.696 0.284 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 53' ' ' VAL . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . 0.413 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 33' ' ' TYR . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.428 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CE2' ' HG ' ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.738 0.304 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.42 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.8 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.337 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.405 ' HB ' ' NH1' ' A' ' 9' ' ' ARG . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.405 ' NH1' ' HB ' ' A' ' 7' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG13 ' CG ' ' A' ' 33' ' ' TYR . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 35' ' ' GLU . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.739 0.304 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -90.17 69.42 7.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -83.81 83.55 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -81.3 152.81 71.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.96 -22.54 35.68 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.562 2.175 . . . . 0.0 112.275 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 67.1 p -90.75 39.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.32 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.42 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.404 ' HA ' ' HA ' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -144.27 123.54 13.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.43 77.47 5.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 6.2 tp -64.97 150.16 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.4 64.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.96 -62.01 1.79 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 6.7 mp -86.49 54.09 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.94 61.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -69.64 130.0 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -102.54 76.27 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.13 88.99 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -120.5 121.05 37.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -161.37 115.77 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.908 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mmt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.845 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.8 114.1 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -170.29 131.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.93 163.35 24.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.69 -27.93 26.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.6 2.2 . . . . 0.0 112.361 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p -90.84 37.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.313 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.422 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.415 HG11 ' CD2' ' A' ' 33' ' ' TYR . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.72 163.47 32.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -142.77 94.03 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.702 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.58 152.91 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -72.63 -26.68 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.9 133.11 39.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.65 53.43 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.03 72.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -97.96 177.09 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -100.94 -177.92 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -127.67 65.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -95.58 77.41 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -169.6 142.92 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.933 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.845 0.355 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -104.21 100.06 9.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -110.18 93.71 4.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 158.15 69.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.977 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -23.02 30.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.384 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 61.4 p -89.89 42.68 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.416 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.42 123.95 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -90.01 82.18 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -62.92 -75.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.94 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 41.0 70.75 0.24 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.531 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -77.6 156.32 30.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.99 -33.35 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -73.86 98.73 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -149.63 159.75 44.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.22 106.75 3.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.95 79.98 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -102.06 -30.56 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -103.19 146.89 27.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.881 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.833 0.349 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.16 89.19 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -113.55 65.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.53 155.22 71.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.72 -20.41 35.03 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.554 2.169 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 60.0 p -90.15 40.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.249 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.421 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 35' ' ' GLU . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.408 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.12 124.17 14.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -88.8 79.1 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 17.6 mt -63.08 158.33 19.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.3 63.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.18 -175.43 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.5 mt -85.38 -23.26 28.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.7 84.9 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -112.93 121.0 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -159.74 144.81 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -135.65 143.59 45.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -96.06 110.39 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -75.02 167.49 21.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.905 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -125.49 111.64 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.7 101.48 8.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.37 158.16 69.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.52 -24.05 31.22 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.554 2.169 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p -90.71 36.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.255 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.405 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -142.32 123.34 14.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.71 77.71 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.29 -24.79 68.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 41.38 53.14 3.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -77.37 175.59 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.6 -30.37 23.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -154.25 146.54 23.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -131.79 103.29 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -141.2 148.45 39.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -104.49 99.83 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -170.22 121.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.869 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.821 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -84.04 78.33 9.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -143.52 97.28 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -81.33 160.33 65.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 -24.2 28.61 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.6 2.2 . . . . 0.0 112.411 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p -87.99 3.49 48.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.43 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.429 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.425 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.429 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.402 ' CG1' ' CD2' ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' ' CG1' ' A' ' 47' ' ' VAL . 0.5 OUTLIER -94.71 162.49 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -142.64 88.4 2.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' O ' ' CB ' ' A' ' 75' ' ' ASP . 0.3 OUTLIER -62.86 -41.75 99.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 8.9 t0 80.65 59.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.64 134.04 38.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 50.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 77.29 65.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.0 33.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -129.05 172.67 11.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -78.03 -61.0 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -134.17 152.55 51.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -105.34 -23.8 12.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.902 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -131.61 84.92 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -173.31 128.68 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -158.75 160.41 29.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 -19.68 16.41 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.607 2.205 . . . . 0.0 112.422 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p -90.77 45.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.446 ' CD1' ' CE2' ' A' ' 33' ' ' TYR . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.45 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.48 161.77 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.69 87.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.552 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 94.1 mt -62.08 110.81 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.238 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.09 65.17 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.734 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.1 112.56 12.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tp -85.96 58.11 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.21 -29.01 62.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.59 -179.06 1.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.61 150.55 31.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -129.1 -174.78 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -135.74 151.24 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -96.92 -23.94 16.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.896 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.817 0.342 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 60.03 50.87 6.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -165.55 128.43 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -158.63 155.2 24.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.27 -19.32 19.88 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.551 2.167 . . . . 0.0 112.436 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 82.1 p -90.09 42.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.373 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.415 ' N ' ' CD2' ' A' ' 63' ' ' LEU . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 16' ' ' LEU . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -143.14 121.71 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -91.94 77.76 5.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.706 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 51.1 mt -62.97 112.09 2.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.015 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.69 64.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.87 113.91 15.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -86.01 -48.42 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.98 161.06 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -129.76 133.29 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.17 -75.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 59.46 42.77 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 61.57 35.16 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -110.19 151.03 27.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.876 0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -95.47 113.2 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -121.03 99.51 6.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.44 163.24 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.38 -20.45 42.26 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.626 2.217 . . . . 0.0 112.391 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.7 p -87.34 -8.99 56.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.35 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.431 HD23 ' CE2' ' A' ' 33' ' ' TYR . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.402 ' CG2' ' HB3' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.431 ' CE2' HD23 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 44' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.4 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.426 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.41 HG13 ' CD1' ' A' ' 33' ' ' TYR . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.38 123.68 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.42 83.51 5.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.679 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.9 mp -62.6 117.13 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.029 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.68 64.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -76.54 146.05 38.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tp -85.66 -31.44 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -73.93 74.22 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -177.18 122.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.4 m170 61.27 39.86 15.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -64.95 132.06 48.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -102.55 -30.41 10.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.0 151.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.2 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -122.44 112.5 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.64 131.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -158.7 162.32 26.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.78 -23.0 17.09 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.611 2.208 . . . . 0.0 112.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p -90.48 44.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.423 ' CG ' ' N ' ' A' ' 42' ' ' ILE . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.423 ' N ' ' CG ' ' A' ' 41' ' ' MET . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.25 156.86 44.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.77 93.7 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -62.63 117.81 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.09 -27.55 61.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.99 133.14 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.41 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 5.9 mp -85.95 -40.03 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -165.83 153.99 10.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -106.6 -29.67 9.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -93.7 149.74 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.954 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 60.17 34.67 21.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -107.83 110.66 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -103.94 141.34 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.915 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.98 93.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -91.81 86.5 5.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -81.25 159.12 68.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.73 -21.23 21.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.501 2.134 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.7 p -90.63 43.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.276 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.413 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.419 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.569 HG21 HG23 ' A' ' 53' ' ' VAL . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . 0.413 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.86 123.17 38.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.88 79.18 4.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 92.1 mt -62.82 109.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -75.27 62.87 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.07 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -162.62 131.22 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.402 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 6.3 mp -87.41 -48.91 7.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.851 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -166.19 123.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -59.14 133.85 56.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -161.39 147.4 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -66.01 170.71 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -160.87 169.51 22.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -98.11 -176.37 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.9 m80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -109.33 97.51 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -172.95 131.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -158.68 160.68 29.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.68 -21.67 14.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -90.46 43.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.361 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 33' ' ' TYR . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -95.41 154.16 17.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.78 84.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.66 117.41 6.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.99 -30.68 63.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 t0 63.75 14.98 8.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.45 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 66.38 9.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.12 129.93 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -152.17 150.57 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.45 129.94 41.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -148.22 159.95 43.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.32 166.14 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -76.73 157.07 31.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -112.63 82.87 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -177.13 131.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -158.73 157.79 28.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.968 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.56 -21.32 29.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.606 2.204 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p -90.47 44.63 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -142.97 159.16 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -142.73 85.41 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.87 -31.94 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 38.18 40.86 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.723 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -77.39 142.23 39.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.5 mt -85.85 -29.88 23.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -164.09 127.18 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -93.19 61.56 3.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -166.58 133.08 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -60.55 -68.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -115.81 137.64 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -140.68 -174.99 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.05 73.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -107.83 65.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.71 156.22 0.09 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.04 -25.38 4.1 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.823 2.349 . . . . 0.0 112.471 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p -90.24 43.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.428 ' HG ' ' CE2' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CE2' ' HG ' ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -141.91 158.98 43.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -142.72 90.5 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.91 121.24 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -73.63 64.72 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.49 147.32 37.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 tp 61.65 29.86 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -74.26 108.71 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.84 80.63 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -101.53 -176.88 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -143.02 -178.12 5.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -143.52 167.22 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -99.53 177.36 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.919 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 79.62 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.43 83.74 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.26 156.59 0.1 OUTLIER Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.19 -12.25 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.744 2.296 . . . . 0.0 112.587 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p -90.6 44.79 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.051 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.424 ' HB3' ' CE2' ' A' ' 33' ' ' TYR . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.17 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.77 88.27 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.79 138.37 58.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -30.92 64.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t0 63.25 15.05 8.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.82 78.82 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -165.83 116.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -136.81 -177.44 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -58.43 139.79 54.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.87 126.66 28.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.6 79.47 2.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -65.43 137.34 57.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.868 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.825 0.345 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -81.8 60.48 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -174.32 124.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -158.71 153.38 20.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.74 -26.16 33.01 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.631 2.221 . . . . 0.0 112.299 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 p -90.27 43.01 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.42 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.42 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.419 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.92 121.77 38.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.37 77.98 7.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.72 176.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -166.33 77.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.33 165.63 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -87.51 46.46 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -166.12 115.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.28 177.67 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -131.72 177.49 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -127.26 -175.34 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -136.02 150.87 49.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -79.95 -178.93 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.886 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.89 83.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -95.79 81.15 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 59.85 156.65 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.82 -12.34 13.53 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.694 2.262 . . . . 0.0 112.663 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 53.8 p -90.92 45.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.132 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.428 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.89 124.36 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.61 78.08 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -63.27 -23.37 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.037 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.5 t0 43.67 52.81 6.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.463 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.73 129.51 35.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.39 27.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -25.81 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.733 0.301 . . . . 0.0 111.005 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -56.46 -28.75 60.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.098 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -95.98 42.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -110.53 121.97 46.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 60.19 37.16 20.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -107.83 35.95 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.0 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.881 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -102.07 34.55 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -105.29 60.48 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.45 159.19 67.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.91 -22.26 31.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.584 2.19 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.2 p -90.29 39.46 0.97 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.216 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.426 ' HG ' ' CZ ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.426 ' CZ ' ' HG ' ' A' ' 8' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.77 121.66 37.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.01 77.69 6.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.57 -41.14 98.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 41.3 53.82 3.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.8 -37.46 35.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.28 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.476 ' N ' ' CD1' ' A' ' 77' ' ' LEU . 3.9 mp 62.17 17.72 9.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.764 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.72 33.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.687 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.01 67.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -81.68 175.05 10.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -100.33 83.57 2.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -160.96 134.79 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -70.48 176.41 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.0 p80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.918 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tpt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.845 0.355 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 59.86 49.93 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -129.07 108.29 10.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -158.62 162.8 25.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.79 -22.98 26.62 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.593 2.195 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 p -90.59 44.65 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.405 ' HB ' ' NH1' ' A' ' 9' ' ' ARG . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.405 ' NH1' ' HB ' ' A' ' 7' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' CG ' HG13 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG13 ' CG ' ' A' ' 33' ' ' TYR . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.39 161.69 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.79 95.36 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.47 115.43 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.92 65.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -75.99 158.59 31.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 tp -85.66 -24.24 27.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.33 92.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 5.8 p80 -111.59 -30.1 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 31.7 p80 44.87 44.45 7.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.418 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -134.69 98.11 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -100.09 87.95 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -98.64 -24.13 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.7 m80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -144.13 111.03 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.27 155.46 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.74 -24.76 54.34 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.517 2.145 . . . . 0.0 112.274 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.4 p -90.22 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.541 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.412 ' CG2' ' HB2' ' A' ' 35' ' ' GLU . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.421 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HB2' ' CG2' ' A' ' 17' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.421 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.541 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.98 121.96 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.17 77.62 6.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.3 mp -63.68 124.77 22.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.803 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -73.02 63.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.39 170.62 16.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt 58.13 48.58 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -165.78 122.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -141.65 152.33 43.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -79.04 150.29 31.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -140.88 157.07 45.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -109.52 -30.52 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -63.08 -23.91 67.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.912 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 67.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.77 HG13 ' NE ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' N ' HG23 ' A' ' 17' ' ' THR . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.602 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.49 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.7 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.815 ' HG2' HG23 ' A' ' 44' ' ' THR . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.51 ' HB2' HD12 ' A' ' 63' ' ' LEU . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.555 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.815 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 HD21 ' A' ' 72' ' ' LEU . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.739 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.602 HG23 HG22 ' A' ' 27' ' ' VAL . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.7 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 36' ' ' MET . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LEU . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.77 ' NE ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.703 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.706 0.289 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' H ' HD13 ' A' ' 8' ' ' LEU . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.518 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 HG23 ' A' ' 53' ' ' VAL . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.442 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.557 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 HD21 ' A' ' 72' ' ' LEU . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 27' ' ' VAL . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 56' ' ' ILE . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.707 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.73 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 10' ' ' SER . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 10' ' ' SER . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.604 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 61.4 p . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.563 ' H ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 69' ' ' VAL . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 35' ' ' GLU . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 53' ' ' VAL . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 44' ' ' THR . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.551 ' H ' HG12 ' A' ' 38' ' ' VAL . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.422 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 36' ' ' MET . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.663 HG12 HD21 ' A' ' 72' ' ' LEU . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.674 HG23 HG22 ' A' ' 27' ' ' VAL . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' HB1' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.873 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HB1' ' HE3' ' A' ' 57' ' ' LYS . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.736 ' CD1' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 8' ' ' LEU . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.736 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.694 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 60.0 p . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.797 HG12 ' HD3' ' A' ' 9' ' ' ARG . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.73 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.797 ' HD3' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 53' ' ' VAL . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.479 ' SD ' HD21 ' A' ' 45' ' ' LEU . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.807 HG12 HD21 ' A' ' 72' ' ' LEU . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 27' ' ' VAL . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 56' ' ' ILE . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.731 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.881 ' HA ' HD23 ' A' ' 16' ' ' LEU . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 7' ' ' VAL . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 10' ' ' SER . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' O ' HD22 ' A' ' 72' ' ' LEU . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.664 0.269 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.572 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.572 ' H ' HD13 ' A' ' 8' ' ' LEU . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 59' ' ' PRO . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 18' ' ' GLN . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 17' ' ' THR . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 53' ' ' VAL . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 44' ' ' THR . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.513 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 43' ' ' MET . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.402 ' H ' HD12 ' A' ' 42' ' ' ILE . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 72' ' ' LEU . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 27' ' ' VAL . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.782 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' HD23 ' A' ' 16' ' ' LEU . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.763 HD22 HG12 ' A' ' 69' ' ' VAL . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.763 HG12 HD22 ' A' ' 63' ' ' LEU . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.659 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.547 0.213 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HE ' HG22 ' A' ' 68' ' ' VAL . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 69' ' ' VAL . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.642 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 53' ' ' VAL . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CE2' HD11 ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HG2' HG23 ' A' ' 44' ' ' THR . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.555 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.431 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.947 HG12 HD21 ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 27' ' ' VAL . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.872 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 69' ' ' VAL . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 8' ' ' LEU . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.858 HG22 HD12 ' A' ' 63' ' ' LEU . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.947 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG12 ' HD3' ' A' ' 71' ' ' ARG . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 69' ' ' VAL . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HD21 ' A' ' 63' ' ' LEU . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 18' ' ' GLN . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG23 ' A' ' 17' ' ' THR . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 53' ' ' VAL . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' HD11 ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.886 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 45' ' ' LEU . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.442 ' H ' HD12 ' A' ' 42' ' ' ILE . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 27' ' ' VAL . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.886 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 56' ' ' ILE . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HG12 ' A' ' 69' ' ' VAL . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.837 HG12 HD22 ' A' ' 63' ' ' LEU . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.693 ' HD3' HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 82.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.67 0.271 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.558 HG12 ' CD ' ' A' ' 71' ' ' ARG . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 59' ' ' PRO . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.414 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 53' ' ' VAL . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.769 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 44' ' ' THR . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' HG12 ' A' ' 38' ' ' VAL . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 43' ' ' MET . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.411 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.769 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.914 HD12 HG12 ' A' ' 69' ' ' VAL . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.504 0.193 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.673 ' NE ' HG22 ' A' ' 68' ' ' VAL . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.877 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.53 HG21 ' OE1' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 53' ' ' VAL . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.823 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.571 ' OH ' HD22 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 44' ' ' THR . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' OE1' HG21 ' A' ' 17' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 39' ' ' MET . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.489 HD11 ' CD ' ' A' ' 35' ' ' GLU . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.907 HG12 HD21 ' A' ' 72' ' ' LEU . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 27' ' ' VAL . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 56' ' ' ILE . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.431 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' CE ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.877 ' HA ' HD23 ' A' ' 16' ' ' LEU . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HB1' ' CE ' ' A' ' 57' ' ' LYS . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.673 HG22 ' NE ' ' A' ' 9' ' ' ARG . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.907 HD21 HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' CD ' ' A' ' 71' ' ' ARG . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.644 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.644 ' H ' HD13 ' A' ' 8' ' ' LEU . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.624 ' OG ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.695 HG21 HD11 ' A' ' 42' ' ' ILE . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 53' ' ' VAL . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.497 ' OH ' HD22 ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.737 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.79 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.713 ' SD ' HD11 ' A' ' 45' ' ' LEU . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 39' ' ' MET . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.549 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.79 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.713 HD11 ' SD ' ' A' ' 36' ' ' MET . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 72' ' ' LEU . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.632 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.871 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' OG ' ' A' ' 10' ' ' SER . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 ' HG ' ' A' ' 63' ' ' LEU . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.642 ' CD ' HG12 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 68.7 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.696 0.284 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' CD ' ' A' ' 71' ' ' ARG . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.634 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.687 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.634 ' OH ' HD12 ' A' ' 8' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 44' ' ' THR . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.49 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 69' ' ' VAL . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 72' ' ' LEU . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HA ' HD23 ' A' ' 16' ' ' LEU . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 45' ' ' LEU . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.697 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' CD ' ' A' ' 71' ' ' ARG . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 42' ' ' ILE . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' OH ' HD12 ' A' ' 8' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.478 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.545 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.432 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD22 HG11 ' A' ' 69' ' ' VAL . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 72' ' ' LEU . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.822 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 27' ' ' VAL . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HD23 ' A' ' 16' ' ' LEU . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' GLY . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 HD22 ' A' ' 45' ' ' LEU . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.593 ' CD ' HG12 ' A' ' 7' ' ' VAL . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.769 HG12 ' CD ' ' A' ' 71' ' ' ARG . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 8' ' ' LEU . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 69' ' ' VAL . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 42' ' ' ILE . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 17' ' ' THR . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 53' ' ' VAL . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.78 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.78 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 72' ' ' LEU . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 27' ' ' VAL . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.001 HD12 HG22 ' A' ' 69' ' ' VAL . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 8' ' ' LEU . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.001 HG22 HD12 ' A' ' 63' ' ' LEU . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.769 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 71' ' ' ARG . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 69' ' ' VAL . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 53' ' ' VAL . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.885 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' OH ' HD12 ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' MET . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.547 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.405 ' H ' HD12 ' A' ' 42' ' ' ILE . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.885 HG23 ' HA ' ' A' ' 29' ' ' ALA . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.777 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 27' ' ' VAL . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.702 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.407 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.868 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG22 HD12 ' A' ' 63' ' ' LEU . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 56' ' ' ILE . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' CD ' ' A' ' 71' ' ' ARG . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.566 ' HE ' HG22 ' A' ' 68' ' ' VAL . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' HG21 ' A' ' 69' ' ' VAL . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.829 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.728 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.543 ' CG ' HG23 ' A' ' 44' ' ' THR . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.719 ' SD ' HD21 ' A' ' 45' ' ' LEU . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 39' ' ' MET . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.554 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.616 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.434 ' H ' HD12 ' A' ' 42' ' ' ILE . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.781 HG12 HD21 ' A' ' 72' ' ' LEU . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.817 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 72' ' ' LEU . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.728 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.829 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.026 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HE ' ' A' ' 9' ' ' ARG . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.026 HG22 HD12 ' A' ' 63' ' ' LEU . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.781 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.738 0.304 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.75 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' H ' HD13 ' A' ' 8' ' ' LEU . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 53' ' ' VAL . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.678 ' CD2' HG11 ' A' ' 53' ' ' VAL . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HG2' HG23 ' A' ' 44' ' ' THR . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.425 ' H ' HD12 ' A' ' 42' ' ' ILE . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.867 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.75 ' HD3' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 53.8 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HE ' HG22 ' A' ' 68' ' ' VAL . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 18' ' ' GLN . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 17' ' ' THR . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 53' ' ' VAL . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.643 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 44' ' ' THR . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.546 ' H ' HG12 ' A' ' 38' ' ' VAL . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.427 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 29' ' ' ALA . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 27' ' ' VAL . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.748 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.899 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' HE ' ' A' ' 9' ' ' ARG . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.899 HG22 HD12 ' A' ' 63' ' ' LEU . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.472 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.52 ' H ' HD13 ' A' ' 8' ' ' LEU . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' VAL . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.565 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.435 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.819 HG12 HD21 ' A' ' 72' ' ' LEU . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 27' ' ' VAL . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.746 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' LEU . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 63' ' ' LEU . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.819 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.337 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.482 HG12 ' CD ' ' A' ' 71' ' ' ARG . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.854 ' NH1' HG13 ' A' ' 68' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.407 ' HB2' HG21 ' A' ' 69' ' ' VAL . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 53' ' ' VAL . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' C ' HG22 ' A' ' 17' ' ' THR . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 17' ' ' THR . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' HG2' ' A' ' 36' ' ' MET . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.935 HG12 HD21 ' A' ' 72' ' ' LEU . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 56' ' ' ILE . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' GLY . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.854 HG13 ' NH1' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.038 HG22 HD12 ' A' ' 63' ' ' LEU . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.482 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.935 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 62.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 59' ' ' PRO . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 42' ' ' ILE . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 53' ' ' VAL . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.755 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 44' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . 0.851 ' SD ' HD21 ' A' ' 45' ' ' LEU . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.548 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.457 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.44 ' H ' HD12 ' A' ' 42' ' ' ILE . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.851 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 HD21 ' A' ' 72' ' ' LEU . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 27' ' ' VAL . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.755 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . 0.862 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' HD23 ' A' ' 63' ' ' LEU . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.739 0.304 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -90.17 69.42 7.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -83.81 83.55 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -81.3 152.81 71.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.96 -22.54 35.68 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.562 2.175 . . . . 0.0 112.275 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 74' ' ' LEU . 67.1 p -90.75 39.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.32 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.77 HG13 ' NE ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' N ' HG23 ' A' ' 17' ' ' THR . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.602 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.49 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.7 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.815 ' HG2' HG23 ' A' ' 44' ' ' THR . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.51 ' HB2' HD12 ' A' ' 63' ' ' LEU . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.555 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.815 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 HD21 ' A' ' 72' ' ' LEU . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.739 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.602 HG23 HG22 ' A' ' 27' ' ' VAL . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.7 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 36' ' ' MET . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LEU . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.77 ' NE ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.703 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -144.27 123.54 13.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.43 77.47 5.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.89 ' HB2' HG22 ' A' ' 6' ' ' THR . 6.2 tp -64.97 150.16 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.4 64.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.96 -62.01 1.79 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.464 HD12 ' N ' ' A' ' 77' ' ' LEU . 6.7 mp -86.49 54.09 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.94 61.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -69.64 130.0 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -102.54 76.27 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.13 88.99 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -120.5 121.05 37.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -161.37 115.77 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.908 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mmt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.845 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.8 114.1 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -170.29 131.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.93 163.35 24.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.69 -27.93 26.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.6 2.2 . . . . 0.0 112.361 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p -90.84 37.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.313 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' H ' HD13 ' A' ' 8' ' ' LEU . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.518 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 HG23 ' A' ' 53' ' ' VAL . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.442 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.557 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 HD21 ' A' ' 72' ' ' LEU . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 27' ' ' VAL . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 56' ' ' ILE . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.707 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.73 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 10' ' ' SER . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 10' ' ' SER . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.604 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.72 163.47 32.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -142.77 94.03 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.702 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.58 152.91 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -72.63 -26.68 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.9 133.11 39.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.65 53.43 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.03 72.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -97.96 177.09 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -100.94 -177.92 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -127.67 65.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -95.58 77.41 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -169.6 142.92 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.933 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.845 0.355 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -104.21 100.06 9.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -110.18 93.71 4.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 158.15 69.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.977 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -23.02 30.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.384 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 HD23 ' A' ' 74' ' ' LEU . 61.4 p -89.89 42.68 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.563 ' H ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 69' ' ' VAL . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 35' ' ' GLU . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 53' ' ' VAL . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 44' ' ' THR . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.551 ' H ' HG12 ' A' ' 38' ' ' VAL . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.422 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 36' ' ' MET . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.663 HG12 HD21 ' A' ' 72' ' ' LEU . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.674 HG23 HG22 ' A' ' 27' ' ' VAL . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' HB1' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.873 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HB1' ' HE3' ' A' ' 57' ' ' LYS . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.736 ' CD1' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 8' ' ' LEU . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.736 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.694 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.42 123.95 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -90.01 82.18 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 6' ' ' THR . 1.6 mm? -62.92 -75.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 41.0 70.75 0.24 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.531 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -77.6 156.32 30.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.99 -33.35 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -73.86 98.73 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -149.63 159.75 44.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.22 106.75 3.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.95 79.98 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -102.06 -30.56 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -103.19 146.89 27.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.881 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.833 0.349 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.16 89.19 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.55 65.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.53 155.22 71.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.72 -20.41 35.03 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.554 2.169 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 74' ' ' LEU . 60.0 p -90.15 40.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.249 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.797 HG12 ' HD3' ' A' ' 9' ' ' ARG . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.73 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.797 ' HD3' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 53' ' ' VAL . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.479 ' SD ' HD21 ' A' ' 45' ' ' LEU . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.807 HG12 HD21 ' A' ' 72' ' ' LEU . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 27' ' ' VAL . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 56' ' ' ILE . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.731 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.881 ' HA ' HD23 ' A' ' 16' ' ' LEU . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 7' ' ' VAL . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 10' ' ' SER . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' O ' HD22 ' A' ' 72' ' ' LEU . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.12 124.17 14.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -88.8 79.1 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.592 ' HG ' HG22 ' A' ' 6' ' ' THR . 17.6 mt -63.08 158.33 19.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.3 63.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.18 -175.43 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.5 mt -85.38 -23.26 28.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.7 84.9 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -112.93 121.0 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -159.74 144.81 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -135.65 143.59 45.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -96.06 110.39 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -75.02 167.49 21.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.905 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -125.49 111.64 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.7 101.48 8.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.37 158.16 69.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.52 -24.05 31.22 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.554 2.169 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 HD23 ' A' ' 74' ' ' LEU . 46.9 p -90.71 36.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.255 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.572 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.572 ' H ' HD13 ' A' ' 8' ' ' LEU . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 59' ' ' PRO . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 18' ' ' GLN . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 17' ' ' THR . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 53' ' ' VAL . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 44' ' ' THR . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.513 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 43' ' ' MET . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.402 ' H ' HD12 ' A' ' 42' ' ' ILE . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 72' ' ' LEU . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 27' ' ' VAL . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.782 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' HD23 ' A' ' 16' ' ' LEU . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.763 HD22 HG12 ' A' ' 69' ' ' VAL . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.763 HG12 HD22 ' A' ' 63' ' ' LEU . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.659 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -142.32 123.34 14.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.71 77.71 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 6' ' ' THR . 3.6 mm? -63.29 -24.79 68.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 41.38 53.14 3.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -77.37 175.59 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.6 -30.37 23.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -154.25 146.54 23.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -131.79 103.29 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -141.2 148.45 39.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -104.49 99.83 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -170.22 121.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.0 p80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.869 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.821 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -84.04 78.33 9.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -143.52 97.28 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.437 ' HB2' HG23 ' A' ' 7' ' ' VAL . 5.8 m-20 -81.33 160.33 65.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 -24.2 28.61 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.6 2.2 . . . . 0.0 112.411 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p -87.99 3.49 48.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.43 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 4' ' ' ASP . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HE ' HG22 ' A' ' 68' ' ' VAL . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 69' ' ' VAL . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.642 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 53' ' ' VAL . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CE2' HD11 ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HG2' HG23 ' A' ' 44' ' ' THR . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.555 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.431 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.947 HG12 HD21 ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.494 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 27' ' ' VAL . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.872 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 69' ' ' VAL . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 8' ' ' LEU . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.858 HG22 HD12 ' A' ' 63' ' ' LEU . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.947 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -94.71 162.49 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -142.64 88.4 2.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -62.86 -41.75 99.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 8.9 t0 80.65 59.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.64 134.04 38.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 50.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 77.29 65.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.0 33.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -129.05 172.67 11.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -78.03 -61.0 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -134.17 152.55 51.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -105.34 -23.8 12.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.902 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -131.61 84.92 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -173.31 128.68 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.5 m-20 -158.75 160.41 29.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 -19.68 16.41 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.607 2.205 . . . . 0.0 112.422 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p -90.77 45.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 4' ' ' ASP . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 69' ' ' VAL . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HD21 ' A' ' 63' ' ' LEU . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 18' ' ' GLN . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG23 ' A' ' 17' ' ' THR . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 53' ' ' VAL . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' HD11 ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.886 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 45' ' ' LEU . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.442 ' H ' HD12 ' A' ' 42' ' ' ILE . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 9.8 p-10 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 27' ' ' VAL . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.886 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 56' ' ' ILE . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HG12 ' A' ' 69' ' ' VAL . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.837 HG12 HD22 ' A' ' 63' ' ' LEU . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.693 ' HD3' HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.48 161.77 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.69 87.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.552 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 50' ' ' ARG . 94.1 mt -62.08 110.81 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.09 65.17 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.734 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.1 112.56 12.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tp -85.96 58.11 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.21 -29.01 62.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.59 -179.06 1.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.61 150.55 31.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -129.1 -174.78 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -135.74 151.24 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -96.92 -23.94 16.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.896 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.817 0.342 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 60.03 50.87 6.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -165.55 128.43 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.812 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -158.63 155.2 24.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.27 -19.32 19.88 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.551 2.167 . . . . 0.0 112.436 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 74' ' ' LEU . 82.1 p -90.09 42.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.373 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 4' ' ' ASP . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 59' ' ' PRO . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.414 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 53' ' ' VAL . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.769 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 44' ' ' THR . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' HG12 ' A' ' 38' ' ' VAL . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 43' ' ' MET . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.411 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.769 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.914 HD12 HG12 ' A' ' 69' ' ' VAL . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -143.14 121.71 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -91.94 77.76 5.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.706 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.629 ' CG ' HG22 ' A' ' 6' ' ' THR . 51.1 mt -62.97 112.09 2.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.015 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.69 64.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.87 113.91 15.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -86.01 -48.42 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.98 161.06 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -129.76 133.29 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.17 -75.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 59.46 42.77 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 61.57 35.16 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -110.19 151.03 27.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.876 0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -95.47 113.2 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 58.1 t30 -121.03 99.51 6.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.44 163.24 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.38 -20.45 42.26 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.626 2.217 . . . . 0.0 112.391 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.734 HG22 HD13 ' A' ' 74' ' ' LEU . 70.7 p -87.34 -8.99 56.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.35 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.673 ' NE ' HG22 ' A' ' 68' ' ' VAL . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.877 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.53 HG21 ' OE1' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 53' ' ' VAL . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.823 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.571 ' OH ' HD22 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 44' ' ' THR . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' OE1' HG21 ' A' ' 17' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 39' ' ' MET . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.489 HD11 ' CD ' ' A' ' 35' ' ' GLU . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.907 HG12 HD21 ' A' ' 72' ' ' LEU . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' OE1' HD21 ' A' ' 74' ' ' LEU . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 27' ' ' VAL . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 56' ' ' ILE . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.431 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' CE ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.877 ' HA ' HD23 ' A' ' 16' ' ' LEU . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HB1' ' CE ' ' A' ' 57' ' ' LYS . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.673 HG22 ' NE ' ' A' ' 9' ' ' ARG . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.907 HD21 HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.38 123.68 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.42 83.51 5.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.679 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.734 HD13 HG22 ' A' ' 6' ' ' THR . 7.9 mp -62.6 117.13 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.68 64.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -76.54 146.05 38.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tp -85.66 -31.44 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -73.93 74.22 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.4 t60 -177.18 122.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.4 m170 61.27 39.86 15.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -64.95 132.06 48.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -102.55 -30.41 10.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.0 151.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.2 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -122.44 112.5 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.64 131.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.822 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.0 m-20 -158.7 162.32 26.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.78 -23.0 17.09 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.611 2.208 . . . . 0.0 112.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p -90.48 44.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 4' ' ' ASP . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.644 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.644 ' H ' HD13 ' A' ' 8' ' ' LEU . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.624 ' OG ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.695 HG21 HD11 ' A' ' 42' ' ' ILE . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 53' ' ' VAL . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.497 ' OH ' HD22 ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.737 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.79 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.713 ' SD ' HD11 ' A' ' 45' ' ' LEU . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 39' ' ' MET . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.549 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.79 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.713 HD11 ' SD ' ' A' ' 36' ' ' MET . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 72' ' ' LEU . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 74' ' ' LEU . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.632 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.871 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' OG ' ' A' ' 10' ' ' SER . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 ' HG ' ' A' ' 63' ' ' LEU . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.642 ' CD ' HG12 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.25 156.86 44.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.77 93.7 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 50' ' ' ARG . 4.0 mm? -62.63 117.81 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.09 -27.55 61.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.99 133.14 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.575 HD12 ' N ' ' A' ' 77' ' ' LEU . 5.9 mp -85.95 -40.03 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -165.83 153.99 10.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -106.6 -29.67 9.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -93.7 149.74 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.954 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 60.17 34.67 21.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -107.83 110.66 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -103.94 141.34 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.915 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.98 93.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -91.81 86.5 5.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.5 m-20 -81.25 159.12 68.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.73 -21.23 21.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.501 2.134 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.703 ' CG2' HD12 ' A' ' 74' ' ' LEU . 68.7 p -90.63 43.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.276 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 4' ' ' ASP . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.634 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.687 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.634 ' OH ' HD12 ' A' ' 8' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 44' ' ' THR . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.49 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 69' ' ' VAL . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 72' ' ' LEU . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HA ' HD23 ' A' ' 16' ' ' LEU . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 45' ' ' LEU . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.697 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -94.86 123.17 38.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -92.88 79.18 4.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 6' ' ' THR . 92.1 mt -62.82 109.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -75.27 62.87 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.07 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -162.62 131.22 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 77' ' ' LEU . 6.3 mp -87.41 -48.91 7.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.851 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -166.19 123.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -59.14 133.85 56.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -161.39 147.4 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -66.01 170.71 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -160.87 169.51 22.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 21.9 p80 -98.11 -176.37 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.9 m80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -109.33 97.51 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -172.95 131.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.79 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.9 m-20 -158.68 160.68 29.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.68 -21.67 14.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -90.46 43.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.361 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 4' ' ' ASP . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 42' ' ' ILE . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' OH ' HD12 ' A' ' 8' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.478 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.545 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.432 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD22 HG11 ' A' ' 69' ' ' VAL . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 72' ' ' LEU . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.822 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 27' ' ' VAL . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HD23 ' A' ' 16' ' ' LEU . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' GLY . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 HD22 ' A' ' 45' ' ' LEU . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.593 ' CD ' HG12 ' A' ' 7' ' ' VAL . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -95.41 154.16 17.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.78 84.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.66 117.41 6.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.99 -30.68 63.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 t0 63.75 14.98 8.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.45 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 66.38 9.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.12 129.93 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -152.17 150.57 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.45 129.94 41.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -148.22 159.95 43.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.32 166.14 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -76.73 157.07 31.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -112.63 82.87 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -177.13 131.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.746 ' O ' HG22 ' A' ' 7' ' ' VAL . 3.2 m-20 -158.73 157.79 28.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.968 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.56 -21.32 29.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.606 2.204 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p -90.47 44.63 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.769 HG12 ' CD ' ' A' ' 71' ' ' ARG . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 8' ' ' LEU . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 69' ' ' VAL . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 42' ' ' ILE . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 17' ' ' THR . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 53' ' ' VAL . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.78 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.78 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 72' ' ' LEU . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 27' ' ' VAL . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD12 HG22 ' A' ' 69' ' ' VAL . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 8' ' ' LEU . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.001 HG22 HD12 ' A' ' 63' ' ' LEU . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.769 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.97 159.16 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -142.73 85.41 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.87 -31.94 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 38.18 40.86 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.723 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -77.39 142.23 39.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.5 mt -85.85 -29.88 23.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -164.09 127.18 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -93.19 61.56 3.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -166.58 133.08 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -60.55 -68.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -115.81 137.64 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -140.68 -174.99 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.05 73.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -107.83 65.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.71 156.22 0.09 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.04 -25.38 4.1 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.823 2.349 . . . . 0.0 112.471 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p -90.24 43.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 71' ' ' ARG . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 69' ' ' VAL . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 53' ' ' VAL . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.885 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' OH ' HD12 ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' MET . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.547 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.405 ' H ' HD12 ' A' ' 42' ' ' ILE . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.2 p-10 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.885 HG23 ' HA ' ' A' ' 29' ' ' ALA . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.777 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 27' ' ' VAL . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.702 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.407 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.868 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG22 HD12 ' A' ' 63' ' ' LEU . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 56' ' ' ILE . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -141.91 158.98 43.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' H ' HD13 ' A' ' 72' ' ' LEU . 2.6 tp10 -142.72 90.5 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.91 121.24 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -73.63 64.72 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.49 147.32 37.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 tp 61.65 29.86 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -74.26 108.71 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.84 80.63 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -101.53 -176.88 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -143.02 -178.12 5.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -143.52 167.22 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -99.53 177.36 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.919 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 79.62 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.43 83.74 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 59.26 156.59 0.1 OUTLIER Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.19 -12.25 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.744 2.296 . . . . 0.0 112.587 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p -90.6 44.79 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.051 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' CD ' ' A' ' 71' ' ' ARG . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.566 ' HE ' HG22 ' A' ' 68' ' ' VAL . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' HG21 ' A' ' 69' ' ' VAL . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.829 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.728 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' CG ' HG23 ' A' ' 44' ' ' THR . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.719 ' SD ' HD21 ' A' ' 45' ' ' LEU . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 39' ' ' MET . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.554 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.616 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.434 ' H ' HD12 ' A' ' 42' ' ' ILE . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.781 HG12 HD21 ' A' ' 72' ' ' LEU . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.817 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 72' ' ' LEU . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.728 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.829 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.026 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HE ' ' A' ' 9' ' ' ARG . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.026 HG22 HD12 ' A' ' 63' ' ' LEU . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.781 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.17 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.77 88.27 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.79 138.37 58.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -30.92 64.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t0 63.25 15.05 8.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.82 78.82 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -165.83 116.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -136.81 -177.44 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -58.43 139.79 54.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.87 126.66 28.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.6 79.47 2.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -65.43 137.34 57.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.868 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.825 0.345 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -81.8 60.48 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -174.32 124.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -158.71 153.38 20.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.74 -26.16 33.01 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.631 2.221 . . . . 0.0 112.299 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.48 HG22 HD23 ' A' ' 74' ' ' LEU . 52.8 p -90.27 43.01 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.75 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' H ' HD13 ' A' ' 8' ' ' LEU . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 53' ' ' VAL . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.678 ' CD2' HG11 ' A' ' 53' ' ' VAL . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HG2' HG23 ' A' ' 44' ' ' THR . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.425 ' H ' HD12 ' A' ' 42' ' ' ILE . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.867 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.75 ' HD3' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.92 121.77 38.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.37 77.98 7.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -62.72 176.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -166.33 77.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.33 165.63 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -87.51 46.46 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -166.12 115.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -92.28 177.67 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -131.72 177.49 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -127.26 -175.34 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -136.02 150.87 49.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.95 -178.93 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.886 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.89 83.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -95.79 81.15 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 59.85 156.65 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.82 -12.34 13.53 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.694 2.262 . . . . 0.0 112.663 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.059 HG22 HD23 ' A' ' 74' ' ' LEU . 53.8 p -90.92 45.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.132 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 4' ' ' ASP . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HE ' HG22 ' A' ' 68' ' ' VAL . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 18' ' ' GLN . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 17' ' ' THR . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 53' ' ' VAL . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.643 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 44' ' ' THR . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.546 ' H ' HG12 ' A' ' 38' ' ' VAL . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.427 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 29' ' ' ALA . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 27' ' ' VAL . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.748 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.899 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' HE ' ' A' ' 9' ' ' ARG . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.899 HG22 HD12 ' A' ' 63' ' ' LEU . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.472 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -141.89 124.36 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.61 78.08 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 1.059 HD23 HG22 ' A' ' 6' ' ' THR . 4.4 mm? -63.27 -23.37 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.037 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.5 t0 43.67 52.81 6.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.463 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.73 129.51 35.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.39 27.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -25.81 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.733 0.301 . . . . 0.0 111.005 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -56.46 -28.75 60.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.098 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -95.98 42.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -110.53 121.97 46.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 60.19 37.16 20.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -107.83 35.95 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.0 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.881 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -102.07 34.55 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -105.29 60.48 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.45 159.19 67.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.91 -22.26 31.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.584 2.19 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 HD23 ' A' ' 74' ' ' LEU . 69.2 p -90.29 39.46 0.97 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.216 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.52 ' H ' HD13 ' A' ' 8' ' ' LEU . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' VAL . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.565 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.435 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.819 HG12 HD21 ' A' ' 72' ' ' LEU . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 27' ' ' VAL . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.746 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' LEU . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 63' ' ' LEU . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.819 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.77 121.66 37.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.01 77.69 6.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 HG22 ' A' ' 6' ' ' THR . 3.4 mm? -63.57 -41.14 98.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 41.3 53.82 3.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.8 -37.46 35.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.28 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 77' ' ' LEU . 3.9 mp 62.17 17.72 9.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.764 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.72 33.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.687 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -60.44 -28.01 67.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -81.68 175.05 10.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -100.33 83.57 2.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -160.96 134.79 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -70.48 176.41 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.0 p80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.918 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tpt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.845 0.355 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 59.86 49.93 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -129.07 108.29 10.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.842 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.6 m-20 -158.62 162.8 25.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.79 -22.98 26.62 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.593 2.195 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 HD23 ' A' ' 74' ' ' LEU . 17.5 p -90.59 44.65 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.842 HG22 ' O ' ' A' ' 4' ' ' ASP . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.854 ' NH1' HG13 ' A' ' 68' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.407 ' HB2' HG21 ' A' ' 69' ' ' VAL . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 53' ' ' VAL . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' C ' HG22 ' A' ' 17' ' ' THR . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 17' ' ' THR . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' HG2' ' A' ' 36' ' ' MET . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.935 HG12 HD21 ' A' ' 72' ' ' LEU . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.583 ' O ' HD13 ' A' ' 74' ' ' LEU . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 56' ' ' ILE . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' GLY . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.854 HG13 ' NH1' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.038 HG22 HD12 ' A' ' 63' ' ' LEU . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.482 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.935 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.39 161.69 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.79 95.36 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 HG22 ' A' ' 6' ' ' THR . 4.4 mm? -62.47 115.43 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.92 65.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -75.99 158.59 31.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 tp -85.66 -24.24 27.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.33 92.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 5.8 p80 -111.59 -30.1 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 31.7 p80 44.87 44.45 7.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.418 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -134.69 98.11 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -100.09 87.95 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -98.64 -24.13 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.7 m80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -144.13 111.03 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.27 155.46 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.74 -24.76 54.34 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.517 2.145 . . . . 0.0 112.274 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 74' ' ' LEU . 62.4 p -90.22 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 59' ' ' PRO . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 42' ' ' ILE . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 53' ' ' VAL . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.755 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 44' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . 0.851 ' SD ' HD21 ' A' ' 45' ' ' LEU . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.548 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.457 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.44 ' H ' HD12 ' A' ' 42' ' ' ILE . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.851 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 HD21 ' A' ' 72' ' ' LEU . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 27' ' ' VAL . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.755 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . 0.862 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' HD23 ' A' ' 63' ' ' LEU . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -95.98 121.96 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.17 77.62 6.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' HB2' HG22 ' A' ' 6' ' ' THR . 3.3 mp -63.68 124.77 22.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.803 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -73.02 63.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.39 170.62 16.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt 58.13 48.58 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -165.78 122.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -141.65 152.33 43.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -79.04 150.29 31.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -140.88 157.07 45.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -109.52 -30.52 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -63.08 -23.91 67.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.912 179.967 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 67.1 p . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.661 0.267 . . . . 0.0 111.32 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.77 HG13 ' NE ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.499 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.407 ' N ' HG23 ' A' ' 17' ' ' THR . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.602 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.49 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.7 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.815 ' HG2' HG23 ' A' ' 44' ' ' THR . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.51 ' HB2' HD12 ' A' ' 63' ' ' LEU . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.555 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.815 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 HD21 ' A' ' 72' ' ' LEU . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.739 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.602 HG23 HG22 ' A' ' 27' ' ' VAL . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.7 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 36' ' ' MET . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LEU . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.77 ' NE ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.703 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.706 0.289 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.549 ' H ' HD13 ' A' ' 8' ' ' LEU . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.518 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 HG23 ' A' ' 53' ' ' VAL . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.442 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.557 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 HD21 ' A' ' 72' ' ' LEU . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 27' ' ' VAL . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 56' ' ' ILE . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.707 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.73 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 10' ' ' SER . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 10' ' ' SER . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.604 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 61.4 p . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.695 0.283 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.563 ' H ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 69' ' ' VAL . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 35' ' ' GLU . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 53' ' ' VAL . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 44' ' ' THR . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.551 ' H ' HG12 ' A' ' 38' ' ' VAL . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.422 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 36' ' ' MET . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.663 HG12 HD21 ' A' ' 72' ' ' LEU . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.674 HG23 HG22 ' A' ' 27' ' ' VAL . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' HB1' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.873 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HB1' ' HE3' ' A' ' 57' ' ' LYS . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.736 ' CD1' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 8' ' ' LEU . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.736 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.694 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 60.0 p . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.692 0.282 . . . . 0.0 111.249 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.797 HG12 ' HD3' ' A' ' 9' ' ' ARG . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.73 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.797 ' HD3' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 53' ' ' VAL . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.479 ' SD ' HD21 ' A' ' 45' ' ' LEU . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.807 HG12 HD21 ' A' ' 72' ' ' LEU . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 27' ' ' VAL . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 56' ' ' ILE . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.731 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.881 ' HA ' HD23 ' A' ' 16' ' ' LEU . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 7' ' ' VAL . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 10' ' ' SER . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.522 ' O ' HD22 ' A' ' 72' ' ' LEU . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 46.9 p . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.664 0.269 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.572 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.572 ' H ' HD13 ' A' ' 8' ' ' LEU . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 59' ' ' PRO . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 18' ' ' GLN . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 17' ' ' THR . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 53' ' ' VAL . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 44' ' ' THR . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.513 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 43' ' ' MET . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.402 ' H ' HD12 ' A' ' 42' ' ' ILE . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 72' ' ' LEU . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 27' ' ' VAL . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.782 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' HD23 ' A' ' 16' ' ' LEU . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.763 HD22 HG12 ' A' ' 69' ' ' VAL . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.763 HG12 HD22 ' A' ' 63' ' ' LEU . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.659 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p . . . . . 0 CA--C 1.53 0.193 0 CA-C-O 120.547 0.213 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HE ' HG22 ' A' ' 68' ' ' VAL . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 69' ' ' VAL . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.642 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 53' ' ' VAL . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CE2' HD11 ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HG2' HG23 ' A' ' 44' ' ' THR . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.555 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.431 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.947 HG12 HD21 ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 27' ' ' VAL . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.872 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 69' ' ' VAL . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 8' ' ' LEU . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.858 HG22 HD12 ' A' ' 63' ' ' LEU . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.947 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.751 0.31 . . . . 0.0 110.992 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.693 HG12 ' HD3' ' A' ' 71' ' ' ARG . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 69' ' ' VAL . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HD21 ' A' ' 63' ' ' LEU . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 18' ' ' GLN . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG23 ' A' ' 17' ' ' THR . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 53' ' ' VAL . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' HD11 ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.886 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.544 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 45' ' ' LEU . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.442 ' H ' HD12 ' A' ' 42' ' ' ILE . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 27' ' ' VAL . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.886 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 56' ' ' ILE . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HG12 ' A' ' 69' ' ' VAL . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.837 HG12 HD22 ' A' ' 63' ' ' LEU . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.693 ' HD3' HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 82.1 p . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.67 0.271 . . . . 0.0 111.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.558 HG12 ' CD ' ' A' ' 71' ' ' ARG . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 59' ' ' PRO . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.414 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 53' ' ' VAL . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.769 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 44' ' ' THR . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' HG12 ' A' ' 38' ' ' VAL . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 43' ' ' MET . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.411 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.769 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.914 HD12 HG12 ' A' ' 69' ' ' VAL . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.7 p . . . . . 0 CA--C 1.528 0.11 0 CA-C-O 120.504 0.193 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.673 ' NE ' HG22 ' A' ' 68' ' ' VAL . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.877 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.53 HG21 ' OE1' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 53' ' ' VAL . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.823 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.571 ' OH ' HD22 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 44' ' ' THR . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.53 ' OE1' HG21 ' A' ' 17' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 39' ' ' MET . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.489 HD11 ' CD ' ' A' ' 35' ' ' GLU . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.907 HG12 HD21 ' A' ' 72' ' ' LEU . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 27' ' ' VAL . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 56' ' ' ILE . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.431 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.435 ' CE ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.877 ' HA ' HD23 ' A' ' 16' ' ' LEU . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HB1' ' CE ' ' A' ' 57' ' ' LYS . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.673 HG22 ' NE ' ' A' ' 9' ' ' ARG . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.907 HD21 HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.758 0.313 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.642 HG12 ' CD ' ' A' ' 71' ' ' ARG . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.644 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.644 ' H ' HD13 ' A' ' 8' ' ' LEU . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.624 ' OG ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.695 HG21 HD11 ' A' ' 42' ' ' ILE . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 53' ' ' VAL . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.497 ' OH ' HD22 ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.737 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.79 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.713 ' SD ' HD11 ' A' ' 45' ' ' LEU . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 39' ' ' MET . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.549 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.79 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.713 HD11 ' SD ' ' A' ' 36' ' ' MET . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 72' ' ' LEU . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.632 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.871 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' OG ' ' A' ' 10' ' ' SER . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 ' HG ' ' A' ' 63' ' ' LEU . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.642 ' CD ' HG12 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.429 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 68.7 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.696 0.284 . . . . 0.0 111.276 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.532 HG12 ' CD ' ' A' ' 71' ' ' ARG . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.634 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.687 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.634 ' OH ' HD12 ' A' ' 8' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 44' ' ' THR . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.49 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 69' ' ' VAL . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 72' ' ' LEU . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HA ' HD23 ' A' ' 16' ' ' LEU . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 45' ' ' LEU . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.532 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.697 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.732 0.301 . . . . 0.0 111.361 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.593 HG12 ' CD ' ' A' ' 71' ' ' ARG . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 42' ' ' ILE . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.641 ' OH ' HD12 ' A' ' 8' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.478 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.545 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.432 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.552 HD22 HG11 ' A' ' 69' ' ' VAL . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 72' ' ' LEU . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.822 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 27' ' ' VAL . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HD23 ' A' ' 16' ' ' LEU . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' GLY . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 HD22 ' A' ' 45' ' ' LEU . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.593 ' CD ' HG12 ' A' ' 7' ' ' VAL . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.769 HG12 ' CD ' ' A' ' 71' ' ' ARG . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 8' ' ' LEU . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 69' ' ' VAL . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 42' ' ' ILE . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 17' ' ' THR . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 53' ' ' VAL . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.78 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.78 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 72' ' ' LEU . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 27' ' ' VAL . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.001 HD12 HG22 ' A' ' 69' ' ' VAL . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 8' ' ' LEU . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.001 HG22 HD12 ' A' ' 63' ' ' LEU . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.769 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.618 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.751 0.31 . . . . 0.0 111.227 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 71' ' ' ARG . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 69' ' ' VAL . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 53' ' ' VAL . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.885 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' OH ' HD12 ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' MET . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.547 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.405 ' H ' HD12 ' A' ' 42' ' ' ILE . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.885 HG23 ' HA ' ' A' ' 29' ' ' ALA . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.777 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 27' ' ' VAL . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.702 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.407 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.868 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.032 HG22 HD12 ' A' ' 63' ' ' LEU . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 56' ' ' ILE . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.791 0.329 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' CD ' ' A' ' 71' ' ' ARG . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.566 ' HE ' HG22 ' A' ' 68' ' ' VAL . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' HG21 ' A' ' 69' ' ' VAL . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.829 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.728 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.543 ' CG ' HG23 ' A' ' 44' ' ' THR . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.719 ' SD ' HD21 ' A' ' 45' ' ' LEU . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 39' ' ' MET . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.554 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.616 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.434 ' H ' HD12 ' A' ' 42' ' ' ILE . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.719 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.781 HG12 HD21 ' A' ' 72' ' ' LEU . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.817 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 72' ' ' LEU . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.728 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.829 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.026 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HE ' ' A' ' 9' ' ' ARG . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.026 HG22 HD12 ' A' ' 63' ' ' LEU . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.564 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.781 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 52.8 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.738 0.304 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.75 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.539 ' H ' HD13 ' A' ' 8' ' ' LEU . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 53' ' ' VAL . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.678 ' CD2' HG11 ' A' ' 53' ' ' VAL . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HG2' HG23 ' A' ' 44' ' ' THR . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.425 ' H ' HD12 ' A' ' 42' ' ' ILE . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.867 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.75 ' HD3' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.402 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 53.8 p . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.761 0.315 . . . . 0.0 111.132 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HE ' HG22 ' A' ' 68' ' ' VAL . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 18' ' ' GLN . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 17' ' ' THR . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 53' ' ' VAL . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.643 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 44' ' ' THR . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.546 ' H ' HG12 ' A' ' 38' ' ' VAL . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.427 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 29' ' ' ALA . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 27' ' ' VAL . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.748 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.899 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' HE ' ' A' ' 9' ' ' ARG . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.899 HG22 HD12 ' A' ' 63' ' ' LEU . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.472 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 69.2 p . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.677 0.275 . . . . 0.0 111.216 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.52 ' H ' HD13 ' A' ' 8' ' ' LEU . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' VAL . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.565 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.435 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.819 HG12 HD21 ' A' ' 72' ' ' LEU . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 27' ' ' VAL . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.746 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' LEU . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 63' ' ' LEU . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.819 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.5 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.807 0.337 . . . . 0.0 111.048 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.482 HG12 ' CD ' ' A' ' 71' ' ' ARG . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.854 ' NH1' HG13 ' A' ' 68' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.407 ' HB2' HG21 ' A' ' 69' ' ' VAL . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 53' ' ' VAL . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.488 ' C ' HG22 ' A' ' 17' ' ' THR . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 17' ' ' THR . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' HG2' ' A' ' 36' ' ' MET . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.935 HG12 HD21 ' A' ' 72' ' ' LEU . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 56' ' ' ILE . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' GLY . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.038 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.854 HG13 ' NH1' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.038 HG22 HD12 ' A' ' 63' ' ' LEU . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.482 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.935 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.404 ' HB ' ' O ' ' A' ' 72' ' ' LEU . 62.4 p . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.766 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.538 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 59' ' ' PRO . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 42' ' ' ILE . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 53' ' ' VAL . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.755 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 44' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . 0.851 ' SD ' HD21 ' A' ' 45' ' ' LEU . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.548 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.457 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.44 ' H ' HD12 ' A' ' 42' ' ' ILE . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.851 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 HD21 ' A' ' 72' ' ' LEU . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 27' ' ' VAL . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.755 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . 0.862 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' HD23 ' A' ' 63' ' ' LEU . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 ttt . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.739 0.304 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.2 mt-10 -90.17 69.42 7.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -83.81 83.55 7.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.979 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -81.3 152.81 71.12 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.841 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -68.96 -22.54 35.68 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.562 2.175 . . . . 0.0 112.275 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.89 HG22 ' HB2' ' A' ' 74' ' ' LEU . 67.1 p -90.75 39.1 0.97 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.32 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.77 HG13 ' NE ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -147.84 176.98 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.878 0.371 . . . . 0.0 111.049 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.628 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.92 141.79 24.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.669 179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.2 mtt180 -149.95 145.09 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 m -68.64 143.61 95.28 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.907 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.59 -25.04 21.35 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.528 2.152 . . . . 0.0 112.332 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 20.1 m -153.38 173.99 14.92 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.922 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.93 123.19 25.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.17 -131.22 1.95 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.579 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.27 140.79 9.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.757 0.313 . . . . 0.0 110.893 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.798 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -68.22 100.93 1.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.446 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -75.78 -44.77 39.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.177 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.407 ' N ' HG23 ' A' ' 17' ' ' THR . 1.4 tt0 -166.95 -160.39 0.39 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.959 -179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 34.4 p90 -149.93 139.69 21.76 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.872 0.368 . . . . 0.0 110.872 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.0 p -96.04 -12.82 24.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.518 -179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.47 142.61 17.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.902 0.382 . . . . 0.0 111.336 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.3 -178.51 1.09 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.943 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -59.77 122.54 14.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.04 25.75 59.27 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.416 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.95 114.19 5.95 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -61.99 120.07 10.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 0.0 110.908 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.602 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.65 136.17 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -84.2 162.72 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.739 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.82 129.82 14.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.429 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.47 -24.37 29.53 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.57 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.9 t -71.68 129.11 37.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.889 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.01 138.02 56.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.49 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.7 p90 -116.32 -13.53 11.04 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.358 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.7 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.56 -170.1 0.66 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.784 0.326 . . . . 0.0 110.981 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.815 ' HG2' HG23 ' A' ' 44' ' ' THR . 32.4 mt-10 -146.06 164.89 30.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.858 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.51 ' HB2' HD12 ' A' ' 63' ' ' LEU . 6.5 ptt? -152.44 117.11 5.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.826 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -89.62 102.83 15.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.023 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.6 165.94 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.551 179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.555 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.5 mtm -55.7 -24.18 33.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.694 0.283 . . . . 0.0 111.271 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.3 mmtm -77.08 -76.18 0.18 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.844 0.354 . . . . 0.0 110.723 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.478 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.2 mtt -151.77 177.07 10.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.2 145.22 8.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.891 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 9.8 mmt -145.68 165.31 29.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.815 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.1 134.54 55.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.853 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.605 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.11 136.29 33.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.645 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -131.79 172.26 12.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.052 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG12 HD21 ' A' ' 72' ' ' LEU . 25.9 m -93.36 151.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.117 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.09 -15.15 42.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.303 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.739 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 38.2 mt-10 -154.79 170.88 20.58 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.804 0.335 . . . . 0.0 110.949 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.42 135.94 52.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.851 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.42 175.11 32.1 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.392 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.37 121.86 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.871 0.367 . . . . 0.0 110.802 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.602 HG23 HG22 ' A' ' 27' ' ' VAL . 26.5 t -81.84 128.79 38.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.182 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.6 mtmp? -116.43 111.09 19.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.696 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.7 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.11 132.28 53.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.324 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.82 -55.86 5.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.366 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -72.1 168.83 17.31 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -92.65 162.65 28.76 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.798 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.5 Cg_endo -66.78 131.88 27.02 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.512 2.141 . . . . 0.0 112.222 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.04 -18.39 51.45 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.713 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.18 144.45 29.62 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.287 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.7 m -78.38 128.6 38.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.966 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.51 HD12 ' HB2' ' A' ' 36' ' ' MET . 11.9 mt -83.49 145.22 29.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.922 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -123.46 146.81 47.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.811 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.521 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.55 97.74 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 117.55 -24.29 9.17 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.631 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.87 146.11 55.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.835 0.35 . . . . 0.0 110.921 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' O ' ' A' ' 8' ' ' LEU . 25.9 t -81.61 105.07 11.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.175 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 20.3 t -82.32 -18.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.425 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.99 -163.7 0.64 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.759 0.314 . . . . 0.0 111.353 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.77 ' NE ' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -139.28 -175.86 4.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.77 -179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.703 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -144.27 123.54 13.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.005 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -91.43 77.47 5.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.714 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.89 ' HB2' HG22 ' A' ' 6' ' ' THR . 6.2 tp -64.97 150.16 48.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.08 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -73.4 64.53 0.83 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.821 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -76.96 -62.01 1.79 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.969 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.464 ' N ' HD12 ' A' ' 77' ' ' LEU . 6.7 mp -86.49 54.09 3.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -74.94 61.88 1.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.977 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -69.64 130.0 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.936 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.8 m-70 -102.54 76.27 1.52 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -135.13 88.99 2.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.893 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -120.5 121.05 37.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 71.5 t60 -161.37 115.77 2.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.847 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.908 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.6 mmt . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.845 0.355 . . . . 0.0 111.185 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -81.8 114.1 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.3 m-20 -170.29 131.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.794 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.93 163.35 24.91 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.878 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.69 -27.93 26.21 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.6 2.2 . . . . 0.0 112.361 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.9 p -90.84 37.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.313 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 14.6 t -148.33 122.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.786 0.327 . . . . 0.0 111.061 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.26 140.27 29.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.924 179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.549 ' H ' HD13 ' A' ' 8' ' ' LEU . 59.8 mtt180 -150.25 138.43 20.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.607 ' OG ' HD23 ' A' ' 63' ' ' LEU . 1.0 OUTLIER -68.83 147.76 97.91 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.986 -179.865 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.88 -26.26 13.48 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.629 2.219 . . . . 0.0 112.272 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.49 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 15.3 m -152.92 175.21 13.18 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.0 128.16 34.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.122 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -150.39 -133.77 2.16 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.46 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.26 139.71 8.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.768 0.318 . . . . 0.0 110.843 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.73 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.4 tp -67.97 97.14 0.65 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.868 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.518 HG21 HD11 ' A' ' 42' ' ' ILE . 15.1 t -76.05 -41.52 50.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.201 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -166.58 -161.05 0.44 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.987 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -149.78 141.21 23.31 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.866 0.365 . . . . 0.0 110.826 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.8 p -96.15 -15.48 22.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.54 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.5 m -149.39 145.82 17.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.94 0.4 . . . . 0.0 111.418 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.29 -178.57 1.1 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.004 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -59.91 126.1 26.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.88 26.72 66.24 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.516 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.87 113.47 5.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.492 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -62.18 121.73 13.84 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 0.0 110.959 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.637 HG22 HG23 ' A' ' 53' ' ' VAL . 32.2 m -146.1 136.61 18.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.249 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -84.39 163.28 19.62 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.793 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.835 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.49 129.99 13.57 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.418 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.8 -26.83 20.58 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.533 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.5 m -71.69 124.74 25.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -67.14 141.31 57.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.442 ' OH ' HD12 ' A' ' 8' ' ' LEU . 45.9 p90 -116.07 -11.5 11.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.349 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -172.77 0.96 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.815 0.34 . . . . 0.0 110.93 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.3 mt-10 -146.73 162.13 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.799 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.466 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.4 ptt? -151.89 123.84 8.07 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.922 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -90.04 110.63 21.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.997 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.557 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.27 171.25 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.63 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.557 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.19 -29.34 65.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.79 0.328 . . . . 0.0 110.808 179.985 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -77.59 -72.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.843 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 27.0 mmm -151.1 -175.93 5.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.518 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.13 150.43 4.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.939 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 16.4 mmm -144.93 160.19 41.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.016 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.467 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.91 133.3 55.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.533 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.7 mp -92.4 131.67 37.38 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.573 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.17 171.46 12.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.01 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.765 HG12 HD21 ' A' ' 72' ' ' LEU . 31.5 m -93.57 154.38 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.205 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.96 -19.54 30.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.18 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.835 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 80.2 mm-40 -154.2 176.37 12.35 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.88 0.372 . . . . 0.0 110.938 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.49 139.65 55.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.903 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.82 175.13 31.51 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.467 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -94.67 120.38 34.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.886 0.374 . . . . 0.0 110.809 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.637 HG23 HG22 ' A' ' 27' ' ' VAL . 22.5 t -81.85 123.98 38.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' HD13 ' A' ' 56' ' ' ILE . 48.6 mttm -115.18 111.14 20.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.617 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.707 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -57.52 131.15 49.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.262 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.405 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.3 mp -104.15 -55.47 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.405 179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.97 167.62 19.74 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.869 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.59 165.42 19.28 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.852 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.73 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.2 Cg_endo -67.07 129.44 20.62 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.51 2.14 . . . . 0.0 112.182 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.55 -15.42 58.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.755 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 144.16 31.79 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.795 0.331 . . . . 0.0 111.359 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 35.3 m -78.31 126.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.024 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.607 HD23 ' OG ' ' A' ' 10' ' ' SER . 8.3 mp -83.32 148.63 27.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.938 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -128.78 147.47 50.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.49 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.58 100.71 0.15 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 116.24 -25.25 9.4 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.568 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.2 t -64.73 147.39 53.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.806 0.336 . . . . 0.0 110.914 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.6 t -81.63 106.8 13.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.107 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.452 HG21 ' OG ' ' A' ' 10' ' ' SER . 14.8 t -81.97 -22.34 9.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.311 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.85 -163.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.113 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.604 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.6 mmm-85 -140.09 -175.69 4.33 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.792 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.765 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.72 163.47 32.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.024 -179.778 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -142.77 94.03 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.702 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.58 152.91 33.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -72.63 -26.68 61.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -76.9 133.11 39.36 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.878 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.2 tp -86.65 53.43 2.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -74.03 72.69 1.66 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.824 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -97.96 177.09 5.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.909 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -100.94 -177.92 3.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.0 p-80 -127.67 65.26 1.35 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.6 m170 -95.58 77.41 3.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.907 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -169.6 142.92 2.64 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.892 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.209 -0.901 . . . . 0.0 110.933 179.973 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.487 1.416 0 CA-C-O 120.845 0.355 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -104.21 100.06 9.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.933 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -110.18 93.71 4.64 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.35 158.15 69.54 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.977 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.95 -23.02 30.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.598 2.199 . . . . 0.0 112.384 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.612 HG22 HD23 ' A' ' 74' ' ' LEU . 61.4 p -89.89 42.68 1.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.694 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -149.01 121.72 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.869 0.366 . . . . 0.0 111.109 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.55 141.1 28.89 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.84 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.563 ' H ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.21 136.46 18.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.918 179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.403 ' HB2' HG21 ' A' ' 69' ' ' VAL . 29.2 t -68.31 146.52 97.97 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.89 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.37 -26.24 14.6 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.58 2.187 . . . . 0.0 112.444 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.5 m -153.15 173.1 15.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.876 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.13 121.5 22.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.168 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.68 -131.22 2.63 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.462 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? -162.27 138.05 7.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.807 0.337 . . . . 0.0 110.838 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.873 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.9 tp -68.07 99.24 0.85 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.819 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.462 HG22 ' C ' ' A' ' 35' ' ' GLU . 14.6 t -76.02 -44.01 41.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.193 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.92 -159.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.97 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 32.0 p90 -149.83 139.68 21.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.857 0.361 . . . . 0.0 110.902 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 9.7 p -95.77 -13.86 23.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.476 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.3 144.15 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.907 0.384 . . . . 0.0 111.339 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.12 -174.56 0.5 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.936 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -59.66 131.89 52.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.855 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.11 27.17 73.38 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.509 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.42 113.47 5.91 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.525 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.24 119.27 8.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 111.04 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.674 HG22 HG23 ' A' ' 53' ' ' VAL . 23.2 m -145.83 137.26 19.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.108 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.15 162.07 20.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.828 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.609 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.42 126.57 9.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.386 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.12 -23.37 36.4 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.736 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.2 m -71.59 131.1 42.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 110.881 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.6 p -67.49 133.75 50.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.095 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 34.4 p90 -113.99 -12.71 12.58 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.224 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.673 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.39 -170.81 0.75 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.913 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' A' ' 44' ' ' THR . 25.1 mt-10 -146.28 160.99 41.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.831 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.503 ' SD ' HD21 ' A' ' 45' ' ' LEU . 7.3 ptt? -152.51 122.92 7.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.868 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -90.1 111.91 23.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.013 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.551 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.55 171.39 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.664 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.551 ' H ' HG12 ' A' ' 38' ' ' VAL . 2.0 mtm -58.37 -28.5 65.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.771 0.32 . . . . 0.0 110.802 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 26.2 mmtt -77.51 -73.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.885 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -151.23 -174.66 4.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.886 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.14 148.74 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.952 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.422 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.0 mtp -145.46 163.53 34.38 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.991 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.825 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 135.46 54.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.838 -179.965 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.503 HD21 ' SD ' ' A' ' 36' ' ' MET . 5.0 mp -92.48 115.3 27.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.747 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -105.95 168.19 9.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.872 -179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.663 HG12 HD21 ' A' ' 72' ' ' LEU . 11.3 m -93.01 147.87 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.937 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.21 -16.93 38.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.418 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 60.9 mm-40 -153.83 167.73 28.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.892 0.377 . . . . 0.0 110.962 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 7.7 mpt_? -68.51 144.08 54.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.034 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 150.66 179.36 26.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.479 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -94.63 124.03 38.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.842 0.353 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.674 HG23 HG22 ' A' ' 27' ' ' VAL . 35.2 t -81.56 126.79 39.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.11 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt -115.2 111.4 20.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.752 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.673 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.01 131.11 49.48 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.293 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.41 -52.62 7.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.373 179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.405 ' HE3' ' HB1' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -72.09 172.36 10.25 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.85 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -92.79 160.56 33.86 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.895 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.873 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.5 Cg_endo -68.09 128.04 16.96 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.518 2.146 . . . . 0.0 112.233 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.89 -16.16 55.75 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.695 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.405 ' HB1' ' HE3' ' A' ' 57' ' ' LYS . . . -56.3 149.22 16.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 111.411 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.64 130.61 35.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.913 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.736 ' CD1' HG22 ' A' ' 69' ' ' VAL . 4.5 mm? -83.35 152.27 25.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.982 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -132.13 146.23 51.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.33 96.1 0.05 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.052 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.03 -23.01 7.45 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.577 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.6 t -64.97 147.09 54.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.863 0.363 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 8' ' ' LEU . 18.7 t -81.52 112.62 19.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.736 HG22 ' CD1' ' A' ' 63' ' ' LEU . 21.4 t -82.17 -26.32 9.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.38 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.24 -166.59 0.91 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.229 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.694 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.81 139.3 32.7 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.855 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.728 HD23 HD23 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -95.42 123.95 39.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.001 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -90.01 82.18 6.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.798 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.612 HD23 HG22 ' A' ' 6' ' ' THR . 1.6 mm? -62.92 -75.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.94 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 15.5 t70 41.0 70.75 0.24 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.531 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -77.6 156.32 30.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.956 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -85.99 -33.35 21.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -73.86 98.73 3.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.951 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.2 t60 -149.63 159.75 44.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -70.22 106.75 3.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.879 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 3.5 t60 -91.95 79.98 5.21 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.886 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -102.06 -30.56 11.1 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -103.19 146.89 27.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.908 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.253 -0.879 . . . . 0.0 110.881 179.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 74.1 mtp . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 120.833 0.349 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -103.16 89.19 3.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.947 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -113.55 65.44 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -81.53 155.22 71.43 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.72 -20.41 35.03 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.554 2.169 . . . . 0.0 112.496 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.592 HG22 ' HG ' ' A' ' 74' ' ' LEU . 60.0 p -90.15 40.82 1.02 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.249 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.797 HG12 ' HD3' ' A' ' 9' ' ' ARG . 6.8 t -148.67 120.63 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.044 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.73 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -91.03 95.53 10.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.479 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.797 ' HD3' HG12 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -92.78 146.09 23.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.86 179.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.464 ' N ' HG23 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -68.63 145.26 96.93 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.903 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.08 -36.44 3.38 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.515 2.143 . . . . 0.0 112.284 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.447 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 5.9 m -153.41 179.72 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.859 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.98 113.73 13.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.125 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -140.93 -135.26 3.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.513 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.27 139.51 8.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.813 0.34 . . . . 0.0 110.871 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.881 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.7 tp -67.93 96.56 0.6 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.748 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.4 t -75.67 -41.11 54.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.187 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.6 -163.11 0.55 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.789 0.328 . . . . 0.0 111.02 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 38.2 p90 -150.25 141.28 22.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.869 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.7 p -96.08 -15.12 22.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.497 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.4 m -149.52 145.07 17.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.876 0.37 . . . . 0.0 111.384 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -68.26 -178.66 1.11 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.934 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.69 121.01 10.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.814 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.69 26.37 56.57 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.416 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.29 114.9 6.03 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.475 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.5 p-80 -62.06 121.48 13.14 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.883 0.373 . . . . 0.0 110.934 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.617 HG22 HG23 ' A' ' 53' ' ' VAL . 26.9 m -145.78 135.89 18.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.123 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -84.09 162.96 20.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.672 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.62 129.4 13.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.435 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.2 -24.17 30.12 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.696 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.2 t -71.74 126.44 29.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.941 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 65.7 p -66.94 136.18 54.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.796 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.609 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.39 -13.32 12.27 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.365 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.731 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.55 -172.55 0.92 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.839 0.352 . . . . 0.0 111.1 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.557 ' HA ' HD12 ' A' ' 45' ' ' LEU . 6.6 mt-10 -146.58 160.33 42.29 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.743 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.479 ' SD ' HD21 ' A' ' 45' ' ' LEU . 8.8 ptm -151.63 128.17 10.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.922 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -90.23 111.44 22.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.877 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.566 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -92.02 172.85 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.747 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.566 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -58.5 -30.03 66.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.77 -179.989 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -77.64 -72.99 0.33 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 1.5 ttp -150.94 -170.0 3.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.937 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.33 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.964 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.43 ' H ' HD12 ' A' ' 42' ' ' ILE . 47.3 mtt -145.03 159.85 42.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.102 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.475 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 132.33 55.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.873 179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.2 mp -92.51 129.94 38.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.708 179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -127.72 172.03 11.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.956 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.807 HG12 HD21 ' A' ' 72' ' ' LEU . 23.7 m -93.67 149.62 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.106 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.02 -15.11 42.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.242 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.672 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 66.7 mm-40 -154.52 171.96 18.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.816 0.341 . . . . 0.0 110.958 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -68.36 134.45 50.28 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.92 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.16 174.05 32.59 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.431 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.5 mtp180 -94.8 121.92 36.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.866 0.365 . . . . 0.0 110.937 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.617 HG23 HG22 ' A' ' 27' ' ' VAL . 21.7 t -82.14 126.86 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.088 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 56' ' ' ILE . 15.5 mmmt -115.81 111.33 20.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.742 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.731 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -57.57 133.18 55.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.24 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.477 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.3 mp -105.3 -56.01 5.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.515 179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.0 173.78 7.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.883 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -92.62 164.06 23.81 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.881 ' HA ' HD23 ' A' ' 16' ' ' LEU . 51.2 Cg_endo -69.18 130.45 20.07 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.474 2.116 . . . . 0.0 112.308 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.77 -16.02 55.73 Favored Glycine 0 CA--C 1.519 0.311 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.791 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.71 146.35 26.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.896 0.379 . . . . 0.0 111.38 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.53 127.59 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.967 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 8.6 mp -83.44 147.83 27.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.943 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -125.1 146.09 49.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.872 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.447 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.57 99.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.062 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.88 -27.0 7.31 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.716 -0.755 . . . . 0.0 112.457 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.5 t -65.07 148.86 50.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.771 0.319 . . . . 0.0 110.847 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.575 HG13 HG12 ' A' ' 7' ' ' VAL . 14.5 t -81.57 114.16 22.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.186 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 10' ' ' SER . 5.8 t -83.43 -28.39 7.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.393 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -159.59 0.4 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.121 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.522 ' O ' HD22 ' A' ' 72' ' ' LEU . 11.7 mmm-85 -138.05 -177.55 4.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.838 0.351 . . . . 0.0 110.891 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.807 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.12 124.17 14.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.918 -179.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -88.8 79.1 7.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.795 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.592 ' HG ' HG22 ' A' ' 6' ' ' THR . 17.6 mt -63.08 158.33 19.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.962 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.3 63.48 0.75 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.936 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -77.18 -175.43 3.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 31.5 mt -85.38 -23.26 28.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.962 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -73.7 84.9 1.62 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.887 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 4.5 t-80 -112.93 121.0 43.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -159.74 144.81 15.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -135.65 143.59 45.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -96.06 110.39 22.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -75.02 167.49 21.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.905 179.942 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.6 mtt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.806 0.336 . . . . 0.0 111.226 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -125.49 111.64 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.887 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -118.7 101.48 8.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -81.37 158.16 69.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.52 -24.05 31.22 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.554 2.169 . . . . 0.0 112.368 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.566 HG22 HD23 ' A' ' 74' ' ' LEU . 46.9 p -90.71 36.79 0.9 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.255 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.659 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.3 t -148.36 120.44 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.849 0.357 . . . . 0.0 111.115 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.572 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -89.71 142.25 27.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.85 179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.572 ' H ' HD13 ' A' ' 8' ' ' LEU . 37.3 mtt180 -150.21 139.45 21.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.24 146.38 97.96 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.908 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.68 -27.35 15.25 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.547 2.164 . . . . 0.0 112.422 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.47 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 12.3 m -153.36 176.02 12.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.908 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.03 117.97 18.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.123 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.62 -131.55 2.81 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.53 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 135.71 6.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.771 0.319 . . . . 0.0 110.925 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.497 HD23 ' HA ' ' A' ' 59' ' ' PRO . 8.7 tp -67.97 100.47 0.98 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.718 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.438 HG23 ' N ' ' A' ' 18' ' ' GLN . 13.4 t -75.5 -46.4 32.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.219 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.438 ' N ' HG23 ' A' ' 17' ' ' THR . 1.8 tt0 -166.58 -160.38 0.41 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.054 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -149.39 140.52 23.03 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.868 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.4 p -95.8 -10.36 29.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.525 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.71 144.82 17.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.863 0.363 . . . . 0.0 111.35 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.36 -178.7 1.14 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.005 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.84 128.36 36.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.754 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.67 26.31 71.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.655 -0.784 . . . . 0.0 112.394 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.73 113.08 5.03 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.547 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.5 p80 -62.45 123.29 17.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.775 0.322 . . . . 0.0 110.967 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.676 HG22 HG23 ' A' ' 53' ' ' VAL . 35.2 m -145.84 138.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.36 161.33 20.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.939 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.826 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.85 130.94 15.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.43 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.71 -25.23 24.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.55 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.3 t -71.82 127.37 32.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.871 0.367 . . . . 0.0 110.851 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.1 p -66.94 138.13 57.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.829 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.3 p90 -114.85 -13.12 12.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.418 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.782 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.4 -169.34 0.61 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.785 0.326 . . . . 0.0 111.006 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.761 ' HG2' HG23 ' A' ' 44' ' ' THR . 29.5 mt-10 -145.77 164.53 31.59 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.74 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.552 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -152.19 120.54 6.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -89.76 103.57 16.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.983 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.5 p -91.54 166.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.622 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 2.4 mtt -55.58 -25.43 38.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.65 0.262 . . . . 0.0 111.246 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.96 -76.01 0.18 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.833 0.349 . . . . 0.0 110.587 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.513 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.3 ttp -151.78 -175.41 5.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.75 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 43' ' ' MET . 7.0 tp -82.28 147.05 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.854 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.402 ' H ' HD12 ' A' ' 42' ' ' ILE . 1.9 mmt -145.52 163.09 35.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.137 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.761 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.04 133.16 55.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.846 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.29 132.33 36.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.616 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -129.84 171.18 12.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.018 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.8 HG12 HD21 ' A' ' 72' ' ' LEU . 27.9 m -93.9 154.1 3.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.169 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.61 -18.43 33.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.2 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.826 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 68.3 mm-40 -153.79 174.68 14.23 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.835 0.35 . . . . 0.0 110.935 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.52 141.69 55.47 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.008 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.96 174.95 28.33 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.488 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.57 121.28 35.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.0 110.777 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.676 HG23 HG22 ' A' ' 27' ' ' VAL . 39.1 t -81.95 126.02 39.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.214 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 36.7 mttp -114.99 109.56 18.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.559 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.782 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.6 135.8 56.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.404 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.416 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.3 mp -105.36 -60.71 2.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.388 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.08 168.56 17.86 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.901 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -92.91 165.1 19.49 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.497 ' HA ' HD23 ' A' ' 16' ' ' LEU . 42.6 Cg_endo -67.64 133.25 29.19 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.579 2.186 . . . . 0.0 112.163 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.25 -22.34 32.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.719 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 143.26 33.88 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.838 0.351 . . . . 0.0 111.363 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 26.9 m -78.41 129.4 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.763 HD22 HG12 ' A' ' 69' ' ' VAL . 12.0 mt -83.93 148.12 27.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.887 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -124.19 148.3 47.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.879 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.47 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.41 96.11 0.05 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.049 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.75 -22.78 8.57 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.592 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 1.2 m -64.75 148.05 51.91 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.826 0.346 . . . . 0.0 110.916 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.0 t -81.64 106.62 12.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.218 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.763 HG12 HD22 ' A' ' 63' ' ' LEU . 4.3 m -82.18 -22.93 9.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.334 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.91 -164.98 0.76 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.15 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.659 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.0 mmm-85 -141.79 -179.8 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.913 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.8 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -142.32 123.34 14.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.97 -179.884 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.71 77.71 7.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.921 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.566 HD23 HG22 ' A' ' 6' ' ' THR . 3.6 mm? -63.29 -24.79 68.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.013 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 41.38 53.14 3.7 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.497 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.1 p30 -77.37 175.59 9.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.8 mt -85.6 -30.37 23.36 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -74.28 69.57 1.59 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.889 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 7.1 t-80 -154.25 146.54 23.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.892 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -131.79 103.29 6.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.903 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -141.2 148.45 39.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.832 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -104.49 99.83 9.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.881 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 55.1 t60 -170.22 121.9 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.234 -0.889 . . . . 0.0 110.869 -179.982 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tpt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.821 0.344 . . . . 0.0 111.212 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -84.04 78.33 9.77 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -143.52 97.28 3.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.893 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.437 ' HB2' HG23 ' A' ' 7' ' ' VAL . 5.8 m-20 -81.33 160.33 65.38 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.05 -24.2 28.61 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.6 2.2 . . . . 0.0 112.411 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 35.4 p -87.99 3.49 48.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.43 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 4' ' ' ASP . 20.5 t -93.55 125.42 46.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.809 0.338 . . . . 0.0 111.278 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.707 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -88.73 139.69 30.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.894 179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.532 ' HE ' HG22 ' A' ' 68' ' ' VAL . 79.9 mtt180 -150.2 141.21 22.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.933 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.533 ' HB2' HG21 ' A' ' 69' ' ' VAL . 13.8 t -68.68 147.98 98.01 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.019 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.15 -25.85 11.24 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.575 2.184 . . . . 0.0 112.411 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -152.9 173.76 14.95 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.939 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.15 129.32 36.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.19 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -152.2 -135.09 2.18 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.432 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.7 tmtt? -162.27 138.79 7.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 110.819 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.872 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.03 97.43 0.68 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.957 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.642 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.45 -41.33 47.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.215 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -166.54 -160.29 0.4 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.986 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -149.61 140.81 23.09 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.862 0.363 . . . . 0.0 110.789 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.37 -14.64 22.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.618 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 30.7 m -149.3 146.83 16.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.901 0.381 . . . . 0.0 111.467 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.3 -179.02 1.18 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.963 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.94 133.98 56.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.723 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 67.94 28.32 73.46 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.389 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.96 112.04 4.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.528 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 21.6 p-80 -62.85 118.8 8.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.88 0.372 . . . . 0.0 111.057 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.683 HG22 HG23 ' A' ' 53' ' ' VAL . 30.2 m -147.1 141.26 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.413 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.98 161.57 19.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.71 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.788 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 128.43 14.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.351 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.09 -24.58 31.55 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.691 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.4 t -71.63 129.54 38.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.897 0.379 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.18 134.84 52.5 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.994 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.633 ' CE2' HD11 ' A' ' 8' ' ' LEU . 15.1 p90 -113.03 -14.12 13.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.23 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.25 -169.8 0.67 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.954 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' HG2' HG23 ' A' ' 44' ' ' THR . 15.9 mt-10 -146.88 163.92 34.55 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.747 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -151.54 128.83 11.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -91.37 108.48 19.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.937 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.555 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.82 170.47 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.613 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.555 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -57.93 -28.42 64.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.802 0.334 . . . . 0.0 110.799 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.1 mmmt -77.8 -73.75 0.29 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.811 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.6 mtp -152.02 -175.2 5.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.642 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.17 149.3 4.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.95 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.431 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.3 mmm -145.22 165.51 28.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.045 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.516 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.63 130.27 55.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 0.9 OUTLIER -92.52 134.33 35.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.639 179.732 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -130.84 177.01 7.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.04 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.947 HG12 HD21 ' A' ' 72' ' ' LEU . 10.7 m -93.13 150.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.996 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.91 -12.62 50.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.609 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.788 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 49.5 mt-10 -154.37 170.54 21.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.359 . . . . 0.0 111.155 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.494 ' O ' HD22 ' A' ' 74' ' ' LEU . 0.7 OUTLIER -68.49 133.58 48.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.804 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 160.71 177.9 34.23 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.36 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.7 mtt180 -93.52 130.85 39.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.029 0.443 . . . . 0.0 111.22 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.683 HG23 HG22 ' A' ' 27' ' ' VAL . 16.5 t -83.91 122.95 38.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.23 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 15.3 mtpp -115.65 108.75 16.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.65 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.534 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 2.7 m-85 -58.02 128.74 38.64 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.3 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.18 -54.64 6.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.346 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -72.06 172.03 10.83 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.825 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -92.69 162.03 30.38 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.906 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.872 ' HA ' HD23 ' A' ' 16' ' ' LEU . 43.1 Cg_endo -67.77 130.46 21.97 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.533 2.155 . . . . 0.0 112.187 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.95 -14.79 59.52 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.714 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.38 146.75 23.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.856 0.36 . . . . 0.0 111.364 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 30.5 m -78.43 129.61 37.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.911 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.858 HD12 HG22 ' A' ' 69' ' ' VAL . 4.2 mm? -83.56 152.62 24.77 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.949 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 64.7 mm-40 -134.0 147.94 51.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.44 94.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.041 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.94 -22.03 7.74 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.512 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.0 t -64.82 147.97 52.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.798 0.332 . . . . 0.0 110.895 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 8' ' ' LEU . 12.0 t -81.6 110.26 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.858 HG22 HD12 ' A' ' 63' ' ' LEU . 21.6 t -81.89 -27.18 9.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.163 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.38 -165.18 0.83 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.062 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.14 140.2 34.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.77 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.947 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -94.71 162.49 13.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -142.64 88.4 2.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.494 HD22 ' O ' ' A' ' 50' ' ' ARG . 0.3 OUTLIER -62.86 -41.75 99.49 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.926 -179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.414 ' CB ' ' O ' ' A' ' 74' ' ' LEU . 8.9 t0 80.65 59.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.945 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -77.64 134.04 38.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.903 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.18 50.34 1.99 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.099 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 77.29 65.76 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -147.0 33.01 0.91 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -129.05 172.67 11.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.921 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.0 m80 -78.03 -61.0 2.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -134.17 152.55 51.88 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.863 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -105.34 -23.8 12.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.129 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.269 -0.872 . . . . 0.0 110.902 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mpp? . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.783 0.325 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -131.61 84.92 2.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.924 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -173.31 128.68 0.45 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.783 ' O ' HG22 ' A' ' 7' ' ' VAL . 1.5 m-20 -158.75 160.41 29.28 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.6 -19.68 16.41 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.607 2.205 . . . . 0.0 112.422 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 34.1 p -90.77 45.2 1.24 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.783 HG22 ' O ' ' A' ' 4' ' ' ASP . 23.3 m -143.57 -174.54 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.271 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.608 HD13 ' HB3' ' A' ' 70' ' ' ALA . 0.4 OUTLIER -147.96 139.17 23.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.942 0.401 . . . . 0.0 110.818 -179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -149.45 140.11 22.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.874 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.632 ' OG ' HG11 ' A' ' 69' ' ' VAL . 1.7 m -68.23 145.31 97.43 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.945 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -73.99 -24.92 14.61 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.576 2.184 . . . . 0.0 112.389 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.6 m -153.27 177.53 10.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.04 118.29 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.433 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -139.22 -136.27 3.37 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.481 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.29 134.24 5.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.759 0.314 . . . . 0.0 110.795 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.546 HD13 HD21 ' A' ' 63' ' ' LEU . 6.4 tp -68.12 98.36 0.78 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.862 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.433 HG23 ' N ' ' A' ' 18' ' ' GLN . 14.6 t -75.71 -46.73 29.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.122 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.433 ' N ' HG23 ' A' ' 17' ' ' THR . 1.3 tt0 -166.7 -162.2 0.49 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.987 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -150.36 139.6 21.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.851 0.358 . . . . 0.0 110.967 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.6 p -96.26 -4.71 41.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.56 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 33' ' ' TYR . 27.1 m -149.8 142.93 17.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.921 0.391 . . . . 0.0 111.406 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.54 -176.27 0.77 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.929 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -59.88 141.97 54.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.747 179.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.26 27.37 62.81 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.436 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.93 111.32 4.1 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.55 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 6.0 t60 -63.35 120.86 12.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.817 0.341 . . . . 0.0 111.138 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.772 HG22 HG23 ' A' ' 53' ' ' VAL . 31.1 m -147.39 142.06 19.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.327 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.93 159.85 20.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.717 179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.785 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.84 131.58 14.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.385 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.8 -25.01 27.1 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.59 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.9 t -71.82 125.95 28.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.788 0.328 . . . . 0.0 110.918 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -66.95 138.07 56.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.862 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.467 ' CE2' HD11 ' A' ' 8' ' ' LEU . 36.6 p90 -113.88 -14.45 12.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.308 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.886 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.03 -168.3 0.55 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.767 0.317 . . . . 0.0 110.968 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.544 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.6 mt-10 -143.14 166.97 23.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.771 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.587 ' HB3' HD11 ' A' ' 45' ' ' LEU . 4.9 ptt? -151.76 122.46 7.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.922 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -90.21 106.08 18.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.93 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.568 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -91.86 172.39 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.675 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.568 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.69 -29.57 66.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.835 0.35 . . . . 0.0 110.83 -179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 54.9 mmtt -77.54 -73.39 0.31 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.853 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 9.6 mtt -151.61 -176.72 5.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.95 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.442 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -82.0 150.58 4.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.442 ' H ' HD12 ' A' ' 42' ' ' ILE . 35.3 mmm -144.64 165.02 29.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.141 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.544 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.95 129.83 54.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.85 -179.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 36' ' ' MET . 4.6 mp -92.34 135.8 33.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.716 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -133.76 175.37 9.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.948 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 31.1 m -93.19 150.07 4.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.894 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.56 -12.8 50.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.407 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.748 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 20.5 mt-10 -154.33 170.03 22.29 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.882 0.372 . . . . 0.0 110.968 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 74' ' ' LEU . 0.2 OUTLIER -68.42 129.37 39.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.889 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.03 177.9 39.06 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.406 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.457 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 13.9 mtt180 -93.23 130.03 39.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.997 0.427 . . . . 0.0 111.229 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.772 HG23 HG22 ' A' ' 27' ' ' VAL . 40.4 t -83.89 121.78 36.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.335 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 mttp -113.99 104.44 12.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.494 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.886 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.5 m-85 -57.38 133.01 54.79 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.524 -179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.434 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.5 mp -106.78 -59.48 3.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.307 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.434 ' N ' HG22 ' A' ' 56' ' ' ILE . 2.4 mmtp -71.87 163.3 28.09 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.812 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.6 163.43 26.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.439 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.4 Cg_endo -65.34 136.47 47.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.603 2.202 . . . . 0.0 112.142 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.63 -24.55 22.96 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.652 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.52 140.4 46.36 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.838 0.351 . . . . 0.0 111.306 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.433 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.4 t -78.51 126.64 38.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.978 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.837 HD22 HG12 ' A' ' 69' ' ' VAL . 11.6 mt -83.04 141.1 32.3 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.873 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -121.07 155.73 33.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.574 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.09 109.76 1.39 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.106 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 104.38 -19.88 41.45 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.71 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 3.3 t -64.33 148.05 51.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.771 0.32 . . . . 0.0 110.94 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.6 t -81.53 104.03 9.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.198 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.837 HG12 HD22 ' A' ' 63' ' ' LEU . 4.6 m -82.49 -24.02 8.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.371 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.608 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -164.74 -165.12 0.88 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.693 ' HD3' HG12 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -139.25 178.68 7.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.461 179.868 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.48 161.77 37.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.917 0.389 . . . . 0.0 111.175 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -142.69 87.47 2.0 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.552 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.744 HD23 ' O ' ' A' ' 50' ' ' ARG . 94.1 mt -62.08 110.81 1.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.238 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.09 65.17 1.1 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.734 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.1 112.56 12.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.945 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.3 tp -85.96 58.11 4.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.885 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -73.21 -29.01 62.51 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.957 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -69.59 -179.06 1.6 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -112.61 150.55 31.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.859 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -129.1 -174.78 3.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.854 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 24.8 m80 -135.74 151.24 49.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -96.92 -23.94 16.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 20.0 t60 . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.896 179.99 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 ptt? . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.817 0.342 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 60.03 50.87 6.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.908 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -165.55 128.43 2.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.868 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.812 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.6 OUTLIER -158.63 155.2 24.65 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.831 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.27 -19.32 19.88 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.551 2.167 . . . . 0.0 112.436 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.629 HG22 ' CG ' ' A' ' 74' ' ' LEU . 82.1 p -90.09 42.48 1.1 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.373 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.812 HG22 ' O ' ' A' ' 4' ' ' ASP . 32.6 m -148.0 179.09 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.853 0.359 . . . . 0.0 111.413 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.8 139.38 22.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.528 179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' H ' HD13 ' A' ' 8' ' ' LEU . 46.2 mtt180 -149.46 145.88 27.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.007 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.5 m -68.32 144.91 97.08 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.78 -26.55 15.79 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.507 2.138 . . . . 0.0 112.323 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -153.66 178.66 9.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.94 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.95 111.67 11.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.122 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -134.18 -134.54 3.44 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.505 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -162.22 136.61 6.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.775 0.321 . . . . 0.0 110.929 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.581 HD23 ' HA ' ' A' ' 59' ' ' PRO . 9.8 tp -68.48 99.66 0.99 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.779 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.414 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.1 t -75.8 -44.64 40.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.262 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -166.69 -161.51 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.714 0.292 . . . . 0.0 111.092 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -149.68 140.08 22.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.918 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.9 p -96.08 -11.58 26.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.506 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 29.8 m -149.41 141.87 17.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.863 0.363 . . . . 0.0 111.403 -179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.22 -177.77 0.94 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.978 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -59.77 122.57 14.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.781 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.31 26.09 60.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.433 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.0 114.46 6.12 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.489 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.6 t60 -61.92 119.75 9.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.857 0.361 . . . . 0.0 111.015 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG22 HG23 ' A' ' 53' ' ' VAL . 27.7 m -145.57 135.77 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.034 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.13 162.36 20.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.703 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.74 129.78 14.17 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.388 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.59 -24.77 27.86 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.618 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 66.6 m -71.66 128.31 35.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 110.903 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 11.1 p -66.94 136.92 56.08 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 44.5 p90 -115.13 -12.45 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.406 -179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.769 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.45 -169.42 0.61 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.931 0.396 . . . . 0.0 111.084 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.57 ' HG2' HG23 ' A' ' 44' ' ' THR . 9.0 mt-10 -146.7 164.39 32.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.753 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.427 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.77 119.02 5.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.922 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -89.53 102.78 15.46 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.963 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.553 HG22 ' N ' ' A' ' 39' ' ' MET . 14.7 p -91.49 166.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.583 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.553 ' N ' HG22 ' A' ' 38' ' ' VAL . 6.6 mtm -55.53 -25.27 36.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.707 0.289 . . . . 0.0 111.289 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -76.91 -76.03 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.697 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.508 ' O ' HG12 ' A' ' 38' ' ' VAL . 9.2 mmm -151.68 -176.16 5.5 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.78 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.411 HD12 ' H ' ' A' ' 43' ' ' MET . 7.1 tp -82.06 147.28 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.874 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.411 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.3 mmt -144.97 161.32 39.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.144 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.92 132.45 55.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.857 -179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.8 mp -92.27 134.31 35.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.561 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -129.66 172.29 11.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.088 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.703 HG23 ' HA ' ' A' ' 29' ' ' ALA . 29.4 m -93.36 150.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.123 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.27 -15.17 41.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.284 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.662 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 40.0 mt-10 -154.51 169.88 22.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.824 0.345 . . . . 0.0 110.952 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -68.55 135.31 51.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.5 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.477 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -94.74 121.32 36.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.813 0.34 . . . . 0.0 110.839 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.601 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -81.91 129.35 37.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.167 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.0 mtmm -116.08 109.82 18.03 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.747 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.769 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.86 135.13 56.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.276 -179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.423 HG22 ' N ' ' A' ' 57' ' ' LYS . 1.4 mp -105.36 -60.13 3.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.469 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.423 ' N ' HG22 ' A' ' 56' ' ' ILE . 4.5 mmtp -72.03 168.77 17.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.955 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.97 165.65 18.16 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.855 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.581 ' HA ' HD23 ' A' ' 16' ' ' LEU . 40.7 Cg_endo -67.2 133.51 30.89 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.58 2.187 . . . . 0.0 112.201 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.22 -21.48 34.48 Favored Glycine 0 CA--C 1.518 0.276 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.731 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.61 138.99 51.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.851 0.357 . . . . 0.0 111.377 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 34.7 m -78.41 127.45 38.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.98 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.914 HD12 HG12 ' A' ' 69' ' ' VAL . 2.3 mm? -83.9 152.59 24.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.002 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -125.43 154.7 41.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.789 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.48 91.62 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.08 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.34 -17.19 9.06 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.771 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.62 145.37 56.27 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.773 0.32 . . . . 0.0 110.98 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.5 t -81.6 105.58 11.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 63' ' ' LEU . 6.3 m -82.69 -22.49 9.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.584 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.14 -164.47 0.7 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.9 0.381 . . . . 0.0 111.555 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.603 ' O ' HD22 ' A' ' 72' ' ' LEU . 7.3 mmm-85 -140.55 -179.4 6.0 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.546 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.663 HD21 HG12 ' A' ' 47' ' ' VAL . 0.6 OUTLIER -143.14 121.71 12.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.901 0.382 . . . . 0.0 111.267 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -91.94 77.76 5.4 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.706 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.629 ' CG ' HG22 ' A' ' 6' ' ' THR . 51.1 mt -62.97 112.09 2.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.015 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -73.69 64.45 0.92 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.801 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -76.87 113.91 15.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.973 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.5 tp -86.01 -48.42 8.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.913 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.98 161.06 17.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.978 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -129.76 133.29 46.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -64.17 -75.88 0.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 59.46 42.77 17.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 61.57 35.16 17.44 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -110.19 151.03 27.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 55.8 t-80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.202 -0.904 . . . . 0.0 110.905 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.0 mtt . . . . . 0 N--CA 1.487 1.409 0 CA-C-O 120.876 0.37 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -95.47 113.2 24.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.915 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -121.03 99.51 6.54 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.914 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.44 163.24 55.44 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.951 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.38 -20.45 42.26 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.626 2.217 . . . . 0.0 112.391 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.734 HG22 HD13 ' A' ' 74' ' ' LEU . 70.7 p -87.34 -8.99 56.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.35 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.3 t -93.25 118.66 39.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.817 0.342 . . . . 0.0 111.18 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.587 ' O ' HG13 ' A' ' 68' ' ' VAL . 0.7 OUTLIER -89.83 135.48 33.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.796 179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.673 ' NE ' HG22 ' A' ' 68' ' ' VAL . 30.0 mtt180 -150.26 140.85 22.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.998 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.37 149.99 97.86 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.065 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.16 -24.71 12.32 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.635 2.224 . . . . 0.0 112.425 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.431 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 2.1 p -152.83 171.24 18.58 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.087 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.53 126.97 31.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.325 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.545 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -147.18 -130.07 2.02 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.339 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 36' ' ' MET . 2.1 tmmm? -162.28 136.19 6.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.74 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.877 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.1 tp -67.53 98.24 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.96 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.53 HG21 ' OE1' ' A' ' 35' ' ' GLU . 7.2 t -76.73 -44.63 32.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.231 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.73 -162.72 0.51 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.915 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -149.71 139.16 21.49 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.823 0.344 . . . . 0.0 110.871 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.8 p -95.54 -7.75 37.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.654 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.2 m -149.97 141.86 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.961 0.41 . . . . 0.0 111.373 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.23 -179.04 1.17 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.012 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -59.81 122.17 13.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.862 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.54 26.59 56.54 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.466 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.54 113.38 5.47 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.512 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -62.2 119.01 8.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.792 0.33 . . . . 0.0 110.99 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.604 HG22 HG23 ' A' ' 53' ' ' VAL . 27.3 m -145.87 138.08 20.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.11 161.25 20.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.822 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.823 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 126.9 10.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.426 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.82 -25.8 26.98 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.675 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.0 t -71.78 131.47 43.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.824 0.345 . . . . 0.0 110.91 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.9 p -66.97 135.56 53.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.851 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.571 ' OH ' HD22 ' A' ' 8' ' ' LEU . 43.4 p90 -114.06 -11.07 12.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.289 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.695 ' O ' HG22 ' A' ' 44' ' ' THR . . . -172.4 -170.41 0.71 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.53 ' OE1' HG21 ' A' ' 17' ' ' THR . 28.6 tt0 -147.22 158.91 44.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.69 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.774 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.9 ptm -150.03 122.23 8.35 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.946 0.403 . . . . 0.0 111.174 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -91.15 104.7 17.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.821 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 39' ' ' MET . 13.2 p -91.24 166.5 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.707 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.54 ' N ' HG22 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -55.39 -25.7 37.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 111.286 -179.428 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 9.4 tptp -76.49 -75.62 0.19 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.646 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -151.27 -179.34 7.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.783 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.489 HD11 ' CD ' ' A' ' 35' ' ' GLU . 7.2 tp -81.9 139.77 17.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.803 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 23.9 ptp -145.94 154.74 42.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.161 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.695 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -117.29 135.02 54.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.774 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.4 mm? -92.44 150.58 20.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.748 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -134.52 176.99 8.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.95 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.907 HG12 HD21 ' A' ' 72' ' ' LEU . 31.6 m -92.73 143.91 10.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.927 179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -85.78 -9.3 57.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.379 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.514 ' OE1' HD21 ' A' ' 74' ' ' LEU . 36.3 mt-10 -154.84 162.75 41.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.873 0.368 . . . . 0.0 110.957 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.5 125.22 25.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 170.67 179.99 42.33 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.518 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 8.1 mtp180 -94.9 123.49 38.4 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.808 0.337 . . . . 0.0 110.866 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.604 HG23 HG22 ' A' ' 27' ' ' VAL . 39.9 t -82.09 126.68 39.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' HD13 ' A' ' 56' ' ' ILE . 13.9 mmtp -116.61 117.58 30.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.741 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.431 ' CE2' HD21 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -58.21 125.04 21.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.247 -179.823 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -104.63 -54.74 6.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.419 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.435 ' CE ' ' HB1' ' A' ' 61' ' ' ALA . 0.0 OUTLIER -72.05 176.35 5.17 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.826 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.94 158.94 36.78 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.965 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.877 ' HA ' HD23 ' A' ' 16' ' ' LEU . 57.7 Cg_endo -71.28 130.02 16.86 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.571 2.18 . . . . 0.0 112.284 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.78 -18.79 41.25 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.762 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.435 ' HB1' ' CE ' ' A' ' 57' ' ' LYS . . . -56.19 149.51 15.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.376 . . . . 0.0 111.576 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.9 t -79.1 127.14 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.955 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 14.0 mt -83.52 151.02 25.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.886 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -127.91 148.24 50.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.35 96.31 0.05 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.022 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.41 -23.49 6.77 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.527 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.3 t -65.32 149.55 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.673 HG22 ' NE ' ' A' ' 9' ' ' ARG . 16.4 t -81.46 113.38 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.997 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 24.5 t -82.52 -28.53 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.386 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.439 ' HB3' HD13 ' A' ' 8' ' ' LEU . . . -165.64 -163.74 0.68 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.847 0.356 . . . . 0.0 111.306 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.66 132.6 29.36 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.907 HD21 HG12 ' A' ' 47' ' ' VAL . 0.3 OUTLIER -94.38 123.68 37.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.719 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.42 83.51 5.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.679 179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.734 HD13 HG22 ' A' ' 6' ' ' THR . 7.9 mp -62.6 117.13 5.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.029 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.68 64.77 0.94 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.805 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -76.54 146.05 38.64 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.89 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.9 tp -85.66 -31.44 22.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.936 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.4 tp10 -73.93 74.22 1.65 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -177.18 122.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.893 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.4 m170 61.27 39.86 15.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.906 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 28.2 p80 -64.95 132.06 48.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.7 p-80 -102.55 -30.41 10.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.962 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -93.0 151.62 19.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.2 t60 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.26 -0.876 . . . . 0.0 110.9 179.977 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mmt . . . . . 0 N--CA 1.487 1.378 0 CA-C-O 120.856 0.36 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.8 mp0 -122.44 112.5 18.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -173.64 131.57 0.44 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.822 ' O ' HG22 ' A' ' 7' ' ' VAL . 4.0 m-20 -158.7 162.32 26.79 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.936 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.78 -23.0 17.09 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.611 2.208 . . . . 0.0 112.431 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.3 p -90.48 44.35 1.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.085 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.822 HG22 ' O ' ' A' ' 4' ' ' ASP . 13.9 m -144.58 -174.6 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.336 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.644 HD13 ' H ' ' A' ' 9' ' ' ARG . 0.2 OUTLIER -148.82 142.82 25.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.784 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.644 ' H ' HD13 ' A' ' 8' ' ' LEU . 9.0 mtt-85 -147.96 141.94 25.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.856 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.624 ' OG ' HD23 ' A' ' 63' ' ' LEU . 0.5 OUTLIER -69.02 146.97 97.65 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.962 -179.923 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -74.05 -27.28 12.11 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.585 2.19 . . . . 0.0 112.261 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.54 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 55.0 p -153.15 170.97 19.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.833 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 107.29 8.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.193 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -128.79 -131.08 3.36 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.516 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.31 139.78 8.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.871 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.0 tp -67.65 97.01 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.835 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.695 HG21 HD11 ' A' ' 42' ' ' ILE . 13.3 t -75.94 -41.35 51.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.202 -179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -167.06 -161.43 0.43 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.898 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -150.34 137.72 19.64 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.818 0.342 . . . . 0.0 110.997 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.8 p -95.15 -13.87 24.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.294 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 36.0 m -149.52 141.53 17.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.904 0.383 . . . . 0.0 111.236 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.99 -175.08 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.928 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -59.41 133.43 56.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.67 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.22 27.11 72.74 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.594 -0.812 . . . . 0.0 112.242 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -66.77 113.83 5.95 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.568 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 46.3 p-80 -62.13 120.44 10.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.837 0.351 . . . . 0.0 110.872 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.632 HG22 HG23 ' A' ' 53' ' ' VAL . 34.1 m -146.24 134.87 16.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.411 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -84.9 166.17 17.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.791 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.631 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.26 129.54 15.5 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.468 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.88 -25.28 25.92 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.711 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t -71.79 126.33 29.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.844 0.354 . . . . 0.0 110.942 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 3.0 p -67.34 139.67 57.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.965 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.497 ' OH ' HD22 ' A' ' 45' ' ' LEU . 38.4 p90 -110.7 -23.68 10.92 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.183 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.737 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.53 150.22 2.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.965 0.412 . . . . 0.0 111.208 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.79 ' CG ' HG23 ' A' ' 44' ' ' THR . 3.8 mt-10 -95.9 163.87 12.97 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.061 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.713 ' SD ' HD11 ' A' ' 45' ' ' LEU . 11.1 ptm -152.38 117.62 5.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.723 179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -90.49 102.5 15.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.549 HG22 ' N ' ' A' ' 39' ' ' MET . 12.7 p -91.7 165.1 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.413 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.549 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.3 mtp -55.8 -23.24 28.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.693 0.282 . . . . 0.0 111.274 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -77.45 -75.99 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.889 0.376 . . . . 0.0 110.873 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.1 OUTLIER -152.02 171.17 18.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.695 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -80.17 137.45 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.727 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.6 ptm -145.22 168.24 20.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.219 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.79 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -120.68 134.82 55.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.914 179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.713 HD11 ' SD ' ' A' ' 36' ' ' MET . 3.1 mp -92.67 139.99 29.99 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.88 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.26 174.35 10.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.627 HG12 HD21 ' A' ' 72' ' ' LEU . 32.6 m -92.8 151.72 3.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.041 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.57 -14.59 45.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.441 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.631 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 47.4 mt-10 -154.96 174.38 15.23 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.934 0.397 . . . . 0.0 111.021 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.711 ' O ' HD13 ' A' ' 74' ' ' LEU . 1.9 mpp_? -68.27 132.33 46.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.888 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 164.42 169.89 28.6 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.21 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.432 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 9.6 mtt180 -93.05 127.37 38.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.072 0.463 . . . . 0.0 111.185 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.632 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.85 127.88 39.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.366 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 20.8 mtmm -117.24 111.63 19.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.489 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.737 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -58.09 135.08 56.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.496 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.6 mp -107.37 -58.46 3.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.292 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.7 mmtp -72.03 172.73 9.51 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.837 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -92.75 164.05 23.59 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.885 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.871 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.4 Cg_endo -67.23 130.06 21.8 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.503 2.135 . . . . 0.0 112.232 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.81 -14.29 60.58 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.725 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 149.06 17.08 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.818 0.342 . . . . 0.0 111.366 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 21.7 t -78.43 124.91 37.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.946 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.624 HD23 ' OG ' ' A' ' 10' ' ' SER . 6.6 mp -83.38 140.84 32.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.96 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -120.66 145.3 47.58 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.54 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 104.51 0.43 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.087 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.79 -24.4 13.23 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.671 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 49.8 t -64.68 149.75 48.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.0 t -81.49 100.72 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.083 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG22 ' HG ' ' A' ' 63' ' ' LEU . 19.4 t -82.44 -18.62 10.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.497 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.47 -165.99 0.92 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.295 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.642 ' CD ' HG12 ' A' ' 7' ' ' VAL . 2.4 mmm-85 -141.22 -176.6 4.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.69 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.627 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -143.25 156.86 44.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.03 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -142.77 93.7 2.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.741 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.711 HD13 ' O ' ' A' ' 50' ' ' ARG . 4.0 mm? -62.63 117.81 6.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.955 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -73.09 -27.55 61.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.021 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -76.99 133.14 39.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.575 ' N ' HD12 ' A' ' 77' ' ' LEU . 5.9 mp -85.95 -40.03 16.3 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.869 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 mt-10 -165.83 153.99 10.95 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 20.6 t-160 -106.6 -29.67 9.48 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.003 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -93.7 149.74 20.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.954 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 60.17 34.67 21.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.955 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -107.83 110.66 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.9 t-80 -103.94 141.34 36.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.913 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 52.9 m80 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.915 -179.997 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 mtt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.769 0.319 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -64.98 93.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 33.2 t30 -91.81 86.5 5.94 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.922 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.837 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.5 m-20 -81.25 159.12 68.46 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -72.73 -21.23 21.95 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.501 2.134 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.703 ' CG2' HD12 ' A' ' 74' ' ' LEU . 68.7 p -90.63 43.31 1.14 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.276 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.837 HG22 ' O ' ' A' ' 4' ' ' ASP . 18.9 m -147.1 174.33 2.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.146 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.634 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.07 91.68 1.88 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.022 0.439 . . . . 0.0 111.136 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 -91.87 147.46 22.96 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.77 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.43 146.93 98.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.787 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.88 -37.66 4.83 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.597 2.198 . . . . 0.0 112.384 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.7 p -153.33 -171.48 3.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.936 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 38' ' ' VAL . . . -75.94 117.77 18.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.084 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -148.58 -141.15 3.43 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.511 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.23 142.2 9.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.796 0.331 . . . . 0.0 110.898 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 59' ' ' PRO . 12.7 tp -67.96 98.09 0.72 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.882 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.448 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -76.51 -41.17 47.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.368 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.54 -159.46 0.36 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.677 0.275 . . . . 0.0 111.144 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.1 p90 -149.12 144.61 26.75 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.81 0.338 . . . . 0.0 110.874 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -96.5 -19.34 19.19 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.509 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 35.0 m -149.01 146.8 17.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.928 0.394 . . . . 0.0 111.444 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.31 -168.15 0.1 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.885 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.26 135.42 57.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.936 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.01 25.87 60.17 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.545 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -59.74 110.86 3.06 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.349 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 31.7 p80 -62.29 123.84 19.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.889 0.376 . . . . 0.0 110.991 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 31.0 m -146.05 136.92 18.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.127 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -84.09 161.22 20.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.687 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.75 125.58 8.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.35 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 -24.48 32.06 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.573 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 50.3 m -71.5 129.83 39.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.803 0.335 . . . . 0.0 110.853 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.4 p -66.9 135.65 54.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.935 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.634 ' OH ' HD12 ' A' ' 8' ' ' LEU . 41.4 p90 -112.67 -13.13 13.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.26 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.24 -170.76 0.76 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.922 0.391 . . . . 0.0 110.965 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.532 ' HG2' HG23 ' A' ' 44' ' ' THR . 20.0 mt-10 -146.53 162.94 37.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.638 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.49 ' SD ' HD21 ' A' ' 45' ' ' LEU . 1.7 ptt? -151.71 119.67 6.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.943 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -90.1 102.97 15.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.96 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.63 166.42 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.577 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 1.0 OUTLIER -55.36 -25.71 36.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.69 0.281 . . . . 0.0 111.314 -179.489 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.4 tptm -76.52 -75.76 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.68 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.507 ' O ' HG12 ' A' ' 38' ' ' VAL . 0.4 OUTLIER -151.61 -177.17 5.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.77 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.448 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.1 146.72 6.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.809 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 8.3 mmt -145.38 159.9 42.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.372 . . . . 0.0 111.219 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.532 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.3 132.04 55.14 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.807 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.602 HD22 HG11 ' A' ' 69' ' ' VAL . 4.1 mp -91.93 134.1 35.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.537 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -129.22 172.85 11.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.935 0.398 . . . . 0.0 111.088 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.697 HG12 HD21 ' A' ' 72' ' ' LEU . 28.8 m -93.93 146.37 6.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.159 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -86.09 -8.63 57.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.384 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 43.9 mt-10 -153.94 164.37 38.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.886 0.374 . . . . 0.0 110.999 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -68.85 134.33 49.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.975 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 159.97 -166.36 35.05 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.593 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.354 0 O-C-N 123.093 -0.063 . . . . 0.0 . 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.059 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.7 mtpt -116.37 115.82 26.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.804 0.335 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.7 m-85 -58.32 136.81 57.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.402 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.58 -50.17 7.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.167 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.24 164.68 25.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.737 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -92.18 163.72 25.96 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.891 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.537 ' HA ' HD23 ' A' ' 16' ' ' LEU . 33.3 Cg_endo -64.27 127.29 18.82 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.535 2.157 . . . . 0.0 112.177 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.76 -12.75 62.66 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.738 -179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.54 140.56 45.96 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.802 0.334 . . . . 0.0 111.347 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 62' ' ' VAL . 35.0 m -78.28 121.89 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.964 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.556 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.11 143.66 30.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.927 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.425 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -121.04 157.67 29.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.749 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.88 87.41 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.922 0.391 . . . . 0.0 110.785 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.32 -13.71 6.59 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.716 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.425 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 48.1 t -64.67 147.09 53.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.792 0.33 . . . . 0.0 110.807 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.2 t -81.13 109.5 15.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.964 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.602 HG11 HD22 ' A' ' 45' ' ' LEU . 17.1 t -82.36 -27.94 8.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.395 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.09 -166.12 0.87 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 0.0 111.332 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.532 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.34 137.06 30.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.715 -179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.697 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -94.86 123.17 38.16 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.978 0.418 . . . . 0.0 111.256 -179.793 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -92.88 79.18 4.68 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.673 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.703 HD12 ' CG2' ' A' ' 6' ' ' THR . 92.1 mt -62.82 109.08 1.33 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.919 0.39 . . . . 0.0 111.025 -179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -75.27 62.87 1.31 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.07 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -162.62 131.22 4.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.931 0.396 . . . . 0.0 111.131 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 77' ' ' LEU . 6.3 mp -87.41 -48.91 7.59 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.851 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.3 tp10 -166.19 123.14 1.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.81 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 77.7 t60 -59.14 133.85 56.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.973 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.5 t60 -161.39 147.4 14.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -66.01 170.71 5.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 21.8 p-80 -160.87 169.51 22.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.877 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 7.7 p-80 -98.11 -176.37 3.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.901 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 23.9 m80 . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.899 179.973 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mmt . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.853 0.359 . . . . 0.0 111.194 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -109.33 97.51 7.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -172.95 131.59 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.79 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.9 m-20 -158.68 160.68 29.25 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.68 -21.67 14.4 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 17.7 p -90.46 43.35 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.361 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.79 HG22 ' O ' ' A' ' 4' ' ' ASP . 32.9 m -146.81 172.16 3.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.224 179.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -149.04 91.17 1.82 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.97 0.414 . . . . 0.0 111.194 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.04 147.69 22.76 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.721 179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.83 144.33 97.24 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.812 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.08 -29.84 9.51 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.507 2.138 . . . . 0.0 112.41 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 m -153.66 -177.89 6.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.946 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.94 112.91 12.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.085 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.525 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -139.75 -142.82 4.28 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.486 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -162.28 140.06 8.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.762 0.315 . . . . 0.0 110.856 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.44 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.7 tp -68.14 97.71 0.73 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.564 HG21 HD11 ' A' ' 42' ' ' ILE . 14.9 t -75.98 -40.98 52.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.257 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.52 -162.11 0.5 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.913 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 40.5 p90 -150.5 137.35 19.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.935 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 p -95.45 -10.35 30.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.446 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 32.5 m -149.72 142.75 17.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 120.837 0.351 . . . . 0.0 111.302 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -68.15 -178.69 1.08 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.97 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -59.73 126.62 28.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.82 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.79 27.54 66.81 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.454 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.49 113.47 5.11 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.475 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 26.2 p-80 -62.07 122.31 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.826 0.346 . . . . 0.0 110.935 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.633 HG22 HG23 ' A' ' 53' ' ' VAL . 32.7 m -145.8 135.75 18.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.207 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.22 163.35 19.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.795 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.822 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.39 129.78 13.19 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.429 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.85 -27.11 19.47 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.559 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 58.0 m -71.82 125.3 26.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.784 0.326 . . . . 0.0 110.906 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.5 p -66.97 142.13 57.36 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.931 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.641 ' OH ' HD12 ' A' ' 8' ' ' LEU . 50.0 p90 -117.18 -10.5 10.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.44 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.697 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.68 -172.27 0.87 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.839 0.352 . . . . 0.0 110.956 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HA ' HD12 ' A' ' 45' ' ' LEU . 5.7 mt-10 -146.73 161.78 39.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.75 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.478 ' SD ' HD21 ' A' ' 45' ' ' LEU . 4.8 ptt? -151.87 123.78 8.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.924 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -90.17 109.95 21.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.11 171.03 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.646 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.545 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.7 OUTLIER -58.27 -29.18 65.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.864 0.364 . . . . 0.0 110.853 179.983 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -77.38 -72.6 0.34 Allowed 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.805 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 12.4 mtm -151.57 -176.45 5.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.935 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.564 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.13 149.51 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.922 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.432 ' H ' HD12 ' A' ' 42' ' ' ILE . 39.8 mtt -145.1 160.9 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.079 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.465 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.75 133.96 55.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.852 -179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.552 HD22 HG11 ' A' ' 69' ' ' VAL . 5.0 mp -92.46 133.47 35.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.68 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.75 169.58 16.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.986 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.802 HG12 HD21 ' A' ' 72' ' ' LEU . 31.0 m -93.57 154.15 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.165 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.34 -18.43 33.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.227 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.822 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 55.3 mt-10 -154.03 176.73 11.87 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.89 0.376 . . . . 0.0 110.92 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -68.58 143.39 54.89 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.988 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.8 173.66 26.5 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.491 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.53 119.61 33.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.85 0.357 . . . . 0.0 110.826 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.633 HG23 HG22 ' A' ' 27' ' ' VAL . 22.8 t -81.77 125.83 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 43.8 mttt -115.64 110.61 19.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.657 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.697 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.4 m-85 -57.93 131.45 50.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.372 -179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.483 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.4 mp -105.15 -55.53 5.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.315 179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 162.12 29.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.14 164.79 21.89 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.44 ' HA ' HD23 ' A' ' 16' ' ' LEU . 26.2 Cg_endo -62.08 128.4 23.98 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.548 2.165 . . . . 0.0 112.133 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.17 -16.43 57.33 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.725 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.51 132.84 52.58 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.914 0.388 . . . . 0.0 111.34 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' GLY . 11.0 p -77.85 121.28 30.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.847 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 mt -83.31 143.95 30.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.022 -179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.409 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.2 pt-20 -117.08 158.46 24.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.668 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.93 87.78 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.949 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 128.19 -17.24 5.96 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.503 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.409 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.4 t -65.13 149.09 50.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.863 0.363 . . . . 0.0 110.857 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.7 108.81 15.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.014 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.552 HG11 HD22 ' A' ' 45' ' ' LEU . 15.4 t -81.82 -26.95 9.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.292 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.26 -166.69 0.92 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.142 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.593 ' CD ' HG12 ' A' ' 7' ' ' VAL . 3.3 mmm-85 -142.74 137.29 29.69 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.921 HD23 HD23 ' A' ' 8' ' ' LEU . 0.2 OUTLIER -95.41 154.16 17.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.925 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -142.78 84.81 1.86 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 9.8 mp -62.66 117.41 6.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.947 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -72.99 -30.68 63.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.939 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 41.4 t0 63.75 14.98 8.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.45 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -85.59 66.38 9.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.897 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -164.12 129.93 2.98 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.066 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.5 t-80 -152.17 150.57 30.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.899 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -66.45 129.94 41.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 2.8 p80 -148.22 159.95 43.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.939 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -79.32 166.14 22.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.92 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 24.4 t-80 -76.73 157.07 31.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.238 -0.886 . . . . 0.0 110.867 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.6 mtt . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.8 0.333 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -112.63 82.87 1.72 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -177.13 131.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.746 ' O ' HG22 ' A' ' 7' ' ' VAL . 3.2 m-20 -158.73 157.79 28.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.968 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.56 -21.32 29.92 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.606 2.204 . . . . 0.0 112.364 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 41.9 p -90.47 44.63 1.21 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.975 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.769 HG12 ' CD ' ' A' ' 71' ' ' ARG . 4.9 m -142.74 -176.6 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.515 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.87 142.79 25.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.881 179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.501 ' H ' HD13 ' A' ' 8' ' ' LEU . 69.4 mtt180 -150.14 143.19 24.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.628 ' OG ' HG21 ' A' ' 69' ' ' VAL . 1.5 m -68.59 146.52 97.73 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.012 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -72.56 -25.79 17.32 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.633 2.222 . . . . 0.0 112.307 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 19.2 m -152.95 178.15 10.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.901 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 116.3 16.45 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.175 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.432 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -138.13 -134.9 3.27 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.492 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -162.27 139.17 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.798 0.332 . . . . 0.0 110.8 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.81 99.01 0.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.887 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.701 HG21 HD11 ' A' ' 42' ' ' ILE . 9.5 t -75.99 -48.65 20.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.3 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.43 ' N ' HG23 ' A' ' 17' ' ' THR . 7.0 pt20 -166.76 -161.54 0.45 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.867 -179.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -150.01 141.02 22.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.831 0.348 . . . . 0.0 110.845 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 15.0 p -94.47 -7.62 40.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.473 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.2 m -150.25 147.41 16.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.86 0.362 . . . . 0.0 111.234 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.02 -178.89 1.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.937 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -59.68 120.89 10.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.952 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.84 29.48 51.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.515 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 114.45 6.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -61.87 121.12 12.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.844 0.354 . . . . 0.0 110.88 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.541 HG22 HG23 ' A' ' 53' ' ' VAL . 27.5 m -145.3 137.46 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.15 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.17 162.23 20.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.953 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -48.02 129.55 14.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.472 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -25.62 23.44 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.72 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 62.8 m -71.76 128.86 37.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.788 0.327 . . . . 0.0 110.984 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.9 p -66.99 138.27 57.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.852 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 14.7 p90 -117.34 -15.8 10.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.443 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -172.7 -170.65 0.7 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.838 0.352 . . . . 0.0 110.942 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.78 ' CG ' HG23 ' A' ' 44' ' ' THR . 13.9 mt-10 -145.58 168.78 19.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.834 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 5.3 ptt? -152.23 122.06 7.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -89.38 102.68 15.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.035 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG22 ' N ' ' A' ' 39' ' ' MET . 14.4 p -91.94 166.16 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.493 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.546 ' N ' HG22 ' A' ' 38' ' ' VAL . 3.1 mtm -55.67 -24.2 32.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.661 0.267 . . . . 0.0 111.257 -179.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 29.0 mmtm -77.11 -76.71 0.16 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.85 0.357 . . . . 0.0 110.587 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.489 ' O ' HG12 ' A' ' 38' ' ' VAL . 5.0 mmm -152.84 176.59 11.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.793 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.701 HD11 HG21 ' A' ' 17' ' ' THR . 7.1 tp -82.51 144.15 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.851 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 13.3 mtt -145.49 171.0 15.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.079 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.78 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 134.6 55.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.853 -179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.443 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.3 mt -92.75 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.767 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -131.38 167.06 19.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.969 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.618 HG12 HD21 ' A' ' 72' ' ' LEU . 22.4 m -92.84 154.51 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.104 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.23 -20.51 30.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.162 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.779 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 51.4 mt-10 -153.81 177.98 10.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.858 0.361 . . . . 0.0 110.949 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.57 146.04 53.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.008 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 153.24 174.13 23.24 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.498 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.6 mpp_? -94.37 123.19 37.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.783 0.325 . . . . 0.0 110.739 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 27' ' ' VAL . 22.0 t -81.87 115.08 23.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.295 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.413 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 1.8 ptmt -113.18 107.19 15.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.594 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -57.91 140.46 52.02 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.396 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.413 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.43 -52.74 7.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.377 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -72.0 172.22 10.42 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -92.83 163.15 26.84 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.722 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.4 Cg_endo -65.95 130.58 24.81 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.569 2.179 . . . . 0.0 112.161 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 -16.73 55.96 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.781 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.53 142.06 40.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.802 0.334 . . . . 0.0 111.385 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.6 t -78.58 122.31 33.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.943 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.001 HD12 HG22 ' A' ' 69' ' ' VAL . 3.3 mm? -83.22 142.63 31.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.955 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -116.65 152.49 34.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.888 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.45 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.63 98.18 0.09 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.069 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.72 -24.88 7.82 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.529 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 36.6 t -64.86 148.68 50.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.792 0.329 . . . . 0.0 110.937 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 8' ' ' LEU . 22.5 t -81.53 106.58 12.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.107 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.001 HG22 HD12 ' A' ' 63' ' ' LEU . 15.3 t -82.17 -20.75 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.398 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.89 -165.86 0.86 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.888 0.375 . . . . 0.0 111.344 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.769 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -141.78 -175.92 4.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.678 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.618 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -142.97 159.16 42.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.95 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 40.7 tp10 -142.73 85.41 1.89 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.859 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.87 -31.94 73.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.886 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 38.18 40.86 0.35 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.723 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -77.39 142.23 39.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.909 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 25.5 mt -85.85 -29.88 23.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -164.09 127.18 2.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -93.19 61.56 3.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 2.4 t60 -166.58 133.08 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.2 m80 -60.55 -68.57 0.29 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -115.81 137.64 51.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.882 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -140.68 -174.99 4.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.864 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 14.4 m170 . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.896 -179.998 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttm . . . . . 0 N--CA 1.486 1.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.213 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -150.05 73.81 1.17 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.92 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -107.83 65.13 0.63 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.909 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 58.71 156.22 0.09 OUTLIER Pre-proline 0 N--CA 1.453 -0.313 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.094 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -81.04 -25.38 4.1 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.823 2.349 . . . . 0.0 112.471 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.3 p -90.24 43.43 1.15 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.535 HG13 ' HD3' ' A' ' 71' ' ' ARG . 21.5 t -147.95 125.55 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.896 0.379 . . . . 0.0 111.147 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 72' ' ' LEU . 0.2 OUTLIER -89.4 147.2 24.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.875 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.583 ' H ' HD13 ' A' ' 8' ' ' LEU . 2.3 mtm180 -148.71 142.45 25.6 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.717 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.589 ' HB2' HG21 ' A' ' 69' ' ' VAL . 25.5 t -68.67 145.25 96.88 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -29.79 11.32 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 99.2 p -153.28 -177.92 6.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.851 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.85 118.73 18.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.108 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.549 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.8 -137.97 3.45 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.49 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 36' ' ' MET . 4.7 tmtt? -162.24 140.48 8.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.697 0.284 . . . . 0.0 110.695 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.868 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.5 tp -67.56 96.19 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.06 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 HG22 ' C ' ' A' ' 35' ' ' GLU . 15.0 t -76.88 -43.67 34.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.291 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.49 -158.86 0.34 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 52.9 p90 -149.66 144.57 26.22 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.819 0.342 . . . . 0.0 110.925 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 p -96.07 -17.26 21.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.504 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 34.8 m -148.83 147.11 17.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.892 0.377 . . . . 0.0 111.399 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.03 -169.55 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.907 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -59.24 134.06 56.66 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.932 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 60.99 25.68 64.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.583 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.48 109.71 2.5 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.309 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 32.6 p-80 -62.48 123.96 19.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.858 0.361 . . . . 0.0 110.998 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 HG22 HG23 ' A' ' 53' ' ' VAL . 28.6 m -146.12 139.47 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.103 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.94 160.5 21.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.856 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.885 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -48.15 129.25 15.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.29 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.32 -23.96 31.2 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.506 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.8 t -71.69 128.77 36.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.796 0.331 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 6.0 p -66.9 130.97 44.89 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.953 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' OH ' HD12 ' A' ' 8' ' ' LEU . 36.3 p90 -110.53 -12.79 14.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.071 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.57 -173.48 1.03 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.611 ' HA ' HD12 ' A' ' 45' ' ' LEU . 7.5 mt-10 -147.25 165.69 29.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.581 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.433 ' HA ' ' O ' ' A' ' 15' ' ' LYS . 0.1 OUTLIER -151.41 124.32 8.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.032 179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -91.05 101.37 14.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.943 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.547 HG22 ' N ' ' A' ' 39' ' ' MET . 14.6 p -91.33 166.32 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.521 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.547 ' N ' HG22 ' A' ' 38' ' ' VAL . 4.4 mtp -55.39 -24.97 32.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.659 0.266 . . . . 0.0 111.298 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -77.19 -76.22 0.18 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.875 0.369 . . . . 0.0 110.673 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtt -152.03 -176.93 5.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.777 179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.421 HD11 HG21 ' A' ' 17' ' ' THR . 7.0 tp -82.11 147.26 6.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.826 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.405 ' H ' HD12 ' A' ' 42' ' ' ILE . 31.0 mtp -145.21 162.6 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.895 0.379 . . . . 0.0 111.239 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.585 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.3 OUTLIER -119.84 131.67 55.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.819 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.611 HD12 ' HA ' ' A' ' 35' ' ' GLU . 5.1 mp -92.53 115.17 27.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.884 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -110.16 172.87 6.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.965 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.885 HG23 ' HA ' ' A' ' 29' ' ' ALA . 30.3 m -93.77 151.55 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.064 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.35 -14.5 43.34 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.431 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.777 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 0.4 OUTLIER -155.29 169.57 23.89 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.786 0.327 . . . . 0.0 111.011 179.819 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.0 130.9 44.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.958 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.65 -168.39 39.53 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.59 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -94.06 -178.38 4.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 0.0 110.627 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 27' ' ' VAL . 21.2 t -151.79 114.24 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.004 0.43 . . . . 0.0 111.318 -179.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 mtpm? -116.32 117.05 28.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.683 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.702 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.6 m-85 -57.73 138.22 55.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.409 -179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.407 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.2 mp -105.2 -52.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.304 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mmtp -72.23 176.1 5.51 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -92.78 163.31 26.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.873 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.868 ' HA ' HD23 ' A' ' 16' ' ' LEU . 44.7 Cg_endo -68.0 128.72 18.19 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.519 2.146 . . . . 0.0 112.226 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 -16.42 56.67 Favored Glycine 0 CA--C 1.519 0.305 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.708 -179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.3 144.65 29.53 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.894 0.378 . . . . 0.0 111.376 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.8 t -78.55 124.61 37.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.919 179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.032 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 144.0 30.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -119.98 152.22 37.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.527 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.6 104.46 0.43 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.106 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.79 -23.3 17.49 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.707 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 46.8 t -64.63 148.39 51.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.777 0.323 . . . . 0.0 110.96 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.67 105.49 11.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.127 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.032 HG22 HD12 ' A' ' 63' ' ' LEU . 15.7 t -82.32 -22.5 9.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.388 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.402 ' HA ' HD13 ' A' ' 56' ' ' ILE . . . -165.74 -160.49 0.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.541 -0.3 . . . . 0.0 111.062 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.535 ' HD3' HG13 ' A' ' 7' ' ' VAL . 2.3 mmm-85 -138.19 -178.78 5.43 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.791 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.787 HD23 HD23 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -141.91 158.98 43.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.923 0.392 . . . . 0.0 111.189 -179.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.419 ' H ' HD13 ' A' ' 72' ' ' LEU . 2.6 tp10 -142.72 90.5 2.22 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.52 179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.91 121.24 12.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.057 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 56.7 m-20 -73.63 64.72 0.92 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.834 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.49 147.32 37.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.7 tp 61.65 29.86 18.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.926 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.6 tp10 -74.26 108.71 7.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -130.84 80.63 1.95 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 4.9 m170 -101.53 -176.88 3.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 21.7 m170 -143.02 -178.12 5.68 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -143.52 167.22 22.73 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.914 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -99.53 177.36 5.19 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.949 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 18.2 p80 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.919 179.988 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 mtt . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.826 0.346 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.54 79.62 6.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.923 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -85.43 83.74 7.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.445 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 59.26 156.59 0.1 OUTLIER Pre-proline 0 N--CA 1.452 -0.339 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.19 -12.25 13.06 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.744 2.296 . . . . 0.0 112.587 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 18.9 p -90.6 44.79 1.22 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.051 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.564 HG12 ' CD ' ' A' ' 71' ' ' ARG . 10.8 m -145.42 177.57 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.335 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.645 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.91 140.69 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.807 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.566 ' HE ' HG22 ' A' ' 68' ' ' VAL . 80.9 mtt180 -149.45 141.83 24.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.821 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.443 ' HB2' HG21 ' A' ' 69' ' ' VAL . 27.7 t -68.66 145.83 97.24 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.946 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.13 -26.03 15.35 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.603 2.202 . . . . 0.0 112.321 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.545 ' HA ' ' HB2' ' A' ' 65' ' ' ALA . 4.6 p -153.03 173.8 14.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.97 121.18 22.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.119 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.56 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -144.16 -132.6 2.58 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.486 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -162.3 140.21 8.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.78 0.324 . . . . 0.0 110.822 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.829 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.2 tp -68.15 96.52 0.64 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.863 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.616 HG21 HD11 ' A' ' 42' ' ' ILE . 14.4 t -76.23 -42.18 46.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.228 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.58 -161.54 0.46 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.992 -179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.1 p90 -150.15 140.74 22.54 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.828 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.0 p -95.58 -13.26 24.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.471 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.7 m -149.58 144.84 17.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.341 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.13 -179.63 1.3 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.916 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.74 125.23 22.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.63 27.31 63.38 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.459 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -69.7 113.32 4.97 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 46.5 p-80 -61.94 120.59 11.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.809 0.338 . . . . 0.0 110.934 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.631 HG22 HG23 ' A' ' 53' ' ' VAL . 27.0 m -145.52 137.87 20.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.123 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.23 161.65 20.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.886 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.817 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.63 130.97 14.47 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.407 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.92 -24.36 28.81 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.687 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.2 t -71.65 130.26 40.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.802 0.334 . . . . 0.0 110.944 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.02 139.98 57.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 45' ' ' LEU . 15.8 p90 -120.1 -14.08 8.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.519 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.728 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.8 -174.8 1.17 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.854 0.359 . . . . 0.0 111.012 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.543 ' CG ' HG23 ' A' ' 44' ' ' THR . 2.3 mp0 -145.2 165.11 29.28 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.698 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.719 ' SD ' HD21 ' A' ' 45' ' ' LEU . 23.0 ptt? -151.52 124.92 8.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -89.93 107.66 19.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.056 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.554 HG12 ' H ' ' A' ' 39' ' ' MET . 1.9 t -92.12 171.17 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.656 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.554 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.9 OUTLIER -58.36 -28.17 64.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.795 0.331 . . . . 0.0 110.858 -179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.9 mptm? -77.6 -74.08 0.27 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.9 mtt -152.0 -176.53 5.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.867 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.616 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.48 149.3 4.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.92 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.434 ' H ' HD12 ' A' ' 42' ' ' ILE . 2.6 mmm -145.44 159.24 43.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.068 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.543 HG23 ' CG ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.03 130.87 54.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.842 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.719 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.5 mm? -91.35 148.26 22.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.812 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -136.3 174.49 10.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.999 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.781 HG12 HD21 ' A' ' 72' ' ' LEU . 10.5 m -93.73 152.87 3.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.063 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -85.33 -21.86 28.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.2 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.817 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 48.9 mt-10 -154.01 174.86 14.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.911 0.386 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -68.69 136.71 53.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.943 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.436 ' HA3' HD12 ' A' ' 72' ' ' LEU . . . 161.49 176.84 34.03 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.546 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.67 119.63 33.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.836 0.351 . . . . 0.0 110.853 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.631 HG23 HG22 ' A' ' 27' ' ' VAL . 24.4 t -82.0 124.55 39.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.136 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 65.5 mttt -116.9 113.55 22.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.696 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.728 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.24 132.34 53.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.93 -51.57 7.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.299 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 169.64 15.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.858 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 9.8 mpt_? -92.73 161.99 30.41 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.839 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.829 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.7 Cg_endo -66.8 128.69 19.36 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.548 2.166 . . . . 0.0 112.16 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.58 -16.65 55.86 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.701 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.67 145.54 28.38 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.831 0.348 . . . . 0.0 111.323 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.5 t -78.53 125.95 38.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.978 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.026 HD12 HG22 ' A' ' 69' ' ' VAL . 3.8 mm? -83.15 144.71 29.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.951 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -121.57 148.89 43.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.846 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' HB2' ' HA ' ' A' ' 12' ' ' SER . . . -61.61 96.18 0.06 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.076 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 121.35 -22.64 7.83 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.598 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 42.6 t -64.64 147.62 52.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.957 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.566 HG22 ' HE ' ' A' ' 9' ' ' ARG . 15.7 t -81.45 105.24 11.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.112 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.026 HG22 HD12 ' A' ' 63' ' ' LEU . 21.2 t -82.31 -18.58 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.538 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.9 -172.71 2.42 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.915 0.388 . . . . 0.0 111.458 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.564 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.2 OUTLIER -142.66 137.66 30.1 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.791 180.0 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.781 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.17 156.94 16.11 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.953 -179.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -142.77 88.27 2.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.827 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 7.3 mp -62.79 138.37 58.51 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.907 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.65 -30.92 64.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.0 t0 63.25 15.05 8.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.441 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 28.2 mt -85.82 78.82 9.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.907 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.5 tt0 -165.83 116.95 1.05 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -136.81 -177.44 4.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -58.43 139.79 54.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.916 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -59.87 126.66 28.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.91 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 -97.6 79.47 2.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 59.0 t-80 -65.43 137.34 57.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.868 -179.985 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.0 ptt? . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.825 0.345 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -81.8 60.48 4.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 47.0 t-20 -174.32 124.0 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.925 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -158.71 153.38 20.84 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.886 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.74 -26.16 33.01 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.631 2.221 . . . . 0.0 112.299 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.48 HG22 HD23 ' A' ' 74' ' ' LEU . 52.8 p -90.27 43.01 1.12 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.204 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.75 HG13 ' HD3' ' A' ' 71' ' ' ARG . 11.7 t -148.67 120.68 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.84 0.352 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD23 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.74 141.08 28.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.828 179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.539 ' H ' HD13 ' A' ' 8' ' ' LEU . 45.9 mtt180 -150.18 141.32 23.08 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.17 145.9 97.8 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -73.98 -31.81 7.68 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.545 2.164 . . . . 0.0 112.373 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 53.6 p -153.02 -176.24 5.68 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.88 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.88 123.09 25.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.136 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -149.8 -139.08 3.02 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.446 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -162.24 141.73 9.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.731 0.301 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.17 96.74 0.66 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.902 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.424 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.21 -42.36 46.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.22 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.38 -163.05 0.56 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.76 0.314 . . . . 0.0 110.957 -179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 47.8 p90 -149.83 141.1 23.17 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.869 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.2 p -95.67 -14.88 23.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.444 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.0 m -149.54 146.04 17.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.38 . . . . 0.0 111.361 -179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.12 -177.98 0.95 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.011 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -59.77 124.06 18.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.867 179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.22 28.28 60.41 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.467 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 118.31 10.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.535 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -62.16 118.92 8.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.806 0.336 . . . . 0.0 110.996 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.605 HG22 HG23 ' A' ' 53' ' ' VAL . 34.5 m -146.39 135.82 17.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.335 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -84.77 163.52 19.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.728 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.91 124.42 7.42 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.38 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.62 -25.66 27.23 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.632 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.7 m -71.68 125.26 26.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.84 0.352 . . . . 0.0 110.909 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.3 p -67.09 140.32 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.965 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.678 ' CD2' HG11 ' A' ' 53' ' ' VAL . 46.6 p90 -114.01 -12.99 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.267 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.29 -170.96 0.77 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.846 0.355 . . . . 0.0 110.895 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.486 ' HG2' HG23 ' A' ' 44' ' ' THR . 12.2 mt-10 -146.72 163.76 34.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.759 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 4.2 ptm -151.74 129.01 11.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -89.71 128.94 36.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.941 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 ' O ' ' N ' ' A' ' 41' ' ' MET . 14.9 p -144.97 153.77 14.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.891 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 77.9 mtp 31.53 37.12 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.543 0.572 . . . . 0.0 112.543 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 38' ' ' VAL . 0.1 OUTLIER 80.08 -21.46 0.33 Allowed 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 179.158 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . 0.466 ' N ' ' O ' ' A' ' 38' ' ' VAL . 2.8 tpt -90.73 135.08 33.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.919 0.39 . . . . 0.0 111.156 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 HD12 ' H ' ' A' ' 43' ' ' MET . 6.8 tp -83.04 151.05 4.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.896 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.425 ' H ' HD12 ' A' ' 42' ' ' ILE . 32.7 mtt -144.36 152.66 41.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.02 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.62 129.76 54.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.903 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.438 ' HB3' ' CE1' ' A' ' 33' ' ' TYR . 4.8 mp -92.45 134.73 34.67 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.627 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -130.79 174.52 9.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.941 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.042 HG12 HD21 ' A' ' 72' ' ' LEU . 14.5 m -93.37 150.68 3.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.074 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -85.44 -14.02 47.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.375 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.815 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 26.3 mt-10 -154.28 176.47 12.26 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.863 0.364 . . . . 0.0 110.98 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -68.45 135.45 51.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 157.07 171.76 23.5 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.439 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.9 mtm-85 -94.46 130.95 40.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 0.0 111.061 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.678 HG11 ' CD2' ' A' ' 33' ' ' TYR . 26.1 t -81.8 128.7 38.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.129 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.4 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 25.3 mtmt -115.93 109.22 17.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.583 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.2 m-85 -57.99 132.61 53.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 -179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.4 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.4 mp -105.64 -55.47 5.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.27 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.4 mmtm -72.01 172.68 9.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.84 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -92.73 163.35 26.32 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.805 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.867 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.47 129.66 21.87 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.512 2.141 . . . . 0.0 112.154 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.14 -16.87 56.21 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.692 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.15 144.69 28.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.837 0.351 . . . . 0.0 111.358 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.4 m -78.47 126.29 38.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.004 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.41 141.17 31.92 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.899 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -116.48 155.79 27.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.618 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.27 105.25 0.58 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.151 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 103.41 -13.63 54.61 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.789 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 2.0 t -64.63 148.29 51.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.846 0.355 . . . . 0.0 110.912 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.4 t -81.55 101.92 6.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.149 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.98 -22.87 9.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.39 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.03 -169.8 1.57 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.191 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.75 ' HD3' HG13 ' A' ' 7' ' ' VAL . 1.0 OUTLIER -142.97 143.74 32.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -179.889 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 1.042 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.92 121.77 38.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.922 179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -89.37 77.98 7.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.48 HD23 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -62.72 176.12 0.72 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -166.33 77.78 0.23 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.894 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -77.33 165.63 24.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.863 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.7 tp -87.51 46.46 1.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.092 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.7 tp10 -166.12 115.82 0.97 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.894 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -92.28 177.67 6.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -131.72 177.49 7.48 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.9 m170 -127.26 -175.34 3.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -136.02 150.87 49.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -79.95 -178.93 6.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 60.5 m80 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.886 -179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.888 0.375 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -70.89 83.24 0.66 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -95.79 81.15 3.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.83 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' HG22 ' A' ' 7' ' ' VAL . 0.3 OUTLIER 59.85 156.65 0.1 Allowed Pre-proline 0 N--CA 1.451 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.922 179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -79.82 -12.34 13.53 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.694 2.262 . . . . 0.0 112.663 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.059 HG22 HD23 ' A' ' 74' ' ' LEU . 53.8 p -90.92 45.14 1.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.132 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.469 HG22 ' O ' ' A' ' 4' ' ' ASP . 14.1 m -145.24 170.46 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.274 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.643 HD12 ' OH ' ' A' ' 33' ' ' TYR . 0.1 OUTLIER -149.05 88.36 1.59 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.002 0.429 . . . . 0.0 111.102 179.927 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HE ' HG22 ' A' ' 68' ' ' VAL . 41.4 mtt180 -92.7 146.29 23.77 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.805 179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -67.59 147.79 98.67 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.837 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -71.28 -35.43 8.5 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.543 2.162 . . . . 0.0 112.387 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 68.4 p -152.95 -177.06 6.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.913 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 111.76 11.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.084 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -136.72 -137.04 3.59 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.25 139.56 8.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.797 0.332 . . . . 0.0 110.877 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.748 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.3 tp -68.1 96.17 0.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.764 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 18' ' ' GLN . 14.6 t -75.82 -40.57 54.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.287 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 17' ' ' THR . 12.8 pt20 -166.99 -163.09 0.51 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.779 0.323 . . . . 0.0 111.02 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -150.12 142.08 23.88 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.821 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -96.07 -16.64 21.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.438 -179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 28.9 m -149.52 143.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.906 0.384 . . . . 0.0 111.381 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.32 -177.09 0.83 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.952 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -59.77 124.21 19.43 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.801 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.39 25.22 66.28 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.399 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -68.3 113.6 5.46 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.527 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -62.22 120.97 11.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.889 0.376 . . . . 0.0 111.002 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.576 HG22 HG23 ' A' ' 53' ' ' VAL . 26.8 m -145.67 136.24 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.089 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -84.23 162.57 20.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.719 ' HA ' HG23 ' A' ' 47' ' ' VAL . . . -47.77 130.91 14.91 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.43 179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.98 -25.28 24.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.633 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 74.6 m -71.69 127.09 31.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.795 0.331 . . . . 0.0 110.932 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.4 p -66.97 137.54 56.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.643 ' OH ' HD12 ' A' ' 8' ' ' LEU . 42.6 p90 -114.47 -13.15 12.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.393 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.75 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.52 -172.98 0.97 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.87 0.367 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.468 ' HG2' HG23 ' A' ' 44' ' ' THR . 5.9 mt-10 -146.89 163.39 36.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.719 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.426 ' SD ' HD21 ' A' ' 45' ' ' LEU . 3.9 ptt? -151.85 122.37 7.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.972 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -90.09 107.79 19.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.895 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.546 HG12 ' H ' ' A' ' 39' ' ' MET . 2.0 t -91.97 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.657 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.546 ' H ' HG12 ' A' ' 38' ' ' VAL . 3.3 mtm -58.07 -28.84 64.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.841 0.353 . . . . 0.0 110.841 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -77.23 -72.73 0.33 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.817 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.0 ttm -151.65 -173.88 4.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.45 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.32 150.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.427 ' H ' HD12 ' A' ' 42' ' ' ILE . 9.4 mmm -144.84 154.9 43.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.092 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.468 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -120.0 131.09 55.03 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.864 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HB3' ' CZ ' ' A' ' 33' ' ' TYR . 3.7 mp -92.78 133.45 36.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.692 179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -129.27 173.31 10.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.017 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 HG23 ' HA ' ' A' ' 29' ' ' ALA . 35.6 m -93.8 149.83 4.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.211 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -85.96 -15.78 40.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.223 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.657 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 57.5 mt-10 -154.45 170.36 21.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.798 0.332 . . . . 0.0 110.932 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -68.37 136.15 52.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.916 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.53 176.65 33.86 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.466 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -95.19 120.52 35.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.813 0.339 . . . . 0.0 110.911 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.576 HG23 HG22 ' A' ' 27' ' ' VAL . 25.8 t -82.12 130.91 34.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.156 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -116.45 110.46 18.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.826 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.75 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -58.09 133.82 55.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.451 HD11 ' CG ' ' A' ' 71' ' ' ARG . 1.5 mp -104.89 -57.75 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.452 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 5.9 mmtt -71.77 166.96 20.93 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.928 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.4 mtm180 -92.25 164.21 23.95 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.748 ' HA ' HD23 ' A' ' 16' ' ' LEU . 37.5 Cg_endo -66.05 130.46 24.39 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.53 2.153 . . . . 0.0 112.253 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.53 -20.67 39.94 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.742 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.55 141.58 42.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.852 0.358 . . . . 0.0 111.397 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 35.5 m -78.6 126.11 38.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.038 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.899 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.57 140.54 32.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -112.37 153.9 26.58 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.482 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.23 105.02 0.54 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.093 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.62 -17.53 39.25 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.776 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 38.9 t -64.84 149.32 49.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.859 0.361 . . . . 0.0 110.913 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.569 HG22 ' HE ' ' A' ' 9' ' ' ARG . 11.2 t -81.39 105.82 11.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.088 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.899 HG22 HD12 ' A' ' 63' ' ' LEU . 21.1 t -82.15 -24.54 9.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.43 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -165.97 -164.29 0.69 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.795 0.331 . . . . 0.0 111.17 -179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.472 ' O ' HD22 ' A' ' 72' ' ' LEU . 4.2 mmm-85 -141.6 -176.61 4.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.873 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.631 HD21 HG12 ' A' ' 47' ' ' VAL . 0.4 OUTLIER -141.89 124.36 15.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.91 -179.964 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -89.61 78.08 7.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.993 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 1.059 HD23 HG22 ' A' ' 6' ' ' THR . 4.4 mm? -63.27 -23.37 67.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.037 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 30.5 t0 43.67 52.81 6.19 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.463 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -77.73 129.51 35.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.875 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mp -89.39 27.89 1.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.468 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -73.91 -25.81 60.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.733 0.301 . . . . 0.0 111.005 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.9 m80 -56.46 -28.75 60.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.098 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -95.98 42.22 1.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.91 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -110.53 121.97 46.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.6 t-160 60.19 37.16 20.82 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.5 t-80 -107.83 35.95 2.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.892 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 36.0 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.881 -179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.9 ttp . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.793 0.33 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -102.07 34.55 2.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.938 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -105.29 60.48 0.68 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.867 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -81.45 159.19 67.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.927 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.91 -22.26 31.64 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.584 2.19 . . . . 0.0 112.436 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.58 HG22 HD23 ' A' ' 74' ' ' LEU . 69.2 p -90.29 39.46 0.97 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.216 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.794 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.1 t -148.56 121.7 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.848 0.356 . . . . 0.0 111.034 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.54 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -89.25 138.22 31.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.892 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.52 ' H ' HD13 ' A' ' 8' ' ' LEU . 57.0 mtm180 -149.29 139.87 22.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.851 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.2 m -68.29 145.52 97.48 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.09 -25.95 15.52 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.527 2.151 . . . . 0.0 112.362 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 82.8 p -153.11 -179.35 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.926 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.99 117.29 17.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.142 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.513 ' O ' HG13 ' A' ' 62' ' ' VAL . . . -141.4 -139.0 3.61 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.507 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.24 142.05 9.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.824 0.345 . . . . 0.0 110.812 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.746 HD23 ' HA ' ' A' ' 59' ' ' PRO . 13.4 tp -68.26 96.5 0.66 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.555 HG21 HD11 ' A' ' 42' ' ' ILE . 15.3 t -75.97 -42.06 49.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.157 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.49 -163.0 0.55 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.98 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.49 142.17 23.64 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.889 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.8 p -95.91 -14.42 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.395 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.1 m -149.37 144.66 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.0 111.329 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.17 -177.29 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.935 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -59.82 123.54 17.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.795 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 77.06 25.82 63.39 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.474 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.29 113.67 5.74 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.463 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -62.02 121.33 12.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 110.982 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.559 HG22 HG23 ' A' ' 53' ' ' VAL . 31.7 m -145.59 139.28 21.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.156 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -84.47 161.23 20.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.706 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.81 129.51 14.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.365 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.8 -22.83 35.74 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.686 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 31.1 t -71.54 127.98 34.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.822 0.344 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.2 p -66.95 135.25 53.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 33.5 p90 -112.43 -15.38 13.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.38 -170.82 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.865 0.364 . . . . 0.0 110.996 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 45' ' ' LEU . 14.4 mt-10 -147.08 165.33 30.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.748 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 3.8 ptt? -151.95 123.13 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.88 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.02 107.84 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.943 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.02 171.42 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.692 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.565 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.9 mtm -58.26 -28.79 65.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.785 0.326 . . . . 0.0 110.798 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -77.61 -73.6 0.3 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.825 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 28.9 mtm -151.26 -176.95 5.77 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.555 HD11 HG21 ' A' ' 17' ' ' THR . 6.9 tp -82.13 150.27 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.938 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.435 ' H ' HD12 ' A' ' 42' ' ' ILE . 7.7 mmm -144.87 161.52 39.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.09 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.486 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.77 131.58 55.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.926 -179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.572 HD12 ' HA ' ' A' ' 35' ' ' GLU . 4.4 mp -92.63 129.9 38.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.659 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -127.93 171.0 12.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.963 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.819 HG12 HD21 ' A' ' 72' ' ' LEU . 35.2 m -93.87 150.0 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.146 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.06 -13.93 45.89 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.298 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.706 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 42.6 mt-10 -154.63 169.49 23.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.82 0.343 . . . . 0.0 110.932 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.43 142.84 55.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 156.37 177.6 29.7 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.502 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -94.57 119.64 33.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.841 0.353 . . . . 0.0 110.801 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 27' ' ' VAL . 33.4 t -82.19 122.45 36.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 0.0 OUTLIER -113.45 112.14 23.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.544 179.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.813 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.3 m-85 -58.08 135.82 57.08 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.393 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.415 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -106.29 -55.89 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.452 179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -71.76 168.97 16.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.981 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.61 166.47 16.78 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.746 ' HA ' HD23 ' A' ' 16' ' ' LEU . 41.7 Cg_endo -67.47 129.38 20.03 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.483 2.122 . . . . 0.0 112.203 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.45 -15.41 58.7 Favored Glycine 0 CA--C 1.519 0.332 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.723 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.32 138.2 51.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.885 0.374 . . . . 0.0 111.32 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.513 HG13 ' O ' ' A' ' 14' ' ' GLY . 21.7 t -78.44 122.31 33.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.613 HD12 HG22 ' A' ' 69' ' ' VAL . 3.4 mm? -83.23 143.54 30.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.0 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG2' ' HB2' ' A' ' 67' ' ' CYS . 1.1 pt-20 -116.64 158.92 22.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.696 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.02 87.47 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.95 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 127.38 -15.67 6.37 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.585 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . 0.414 ' HB2' ' HG2' ' A' ' 64' ' ' GLU . 53.1 t -64.86 145.31 56.45 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 8' ' ' LEU . 16.5 t -81.55 109.41 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.973 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.613 HG22 HD12 ' A' ' 63' ' ' LEU . 21.3 t -81.65 -24.42 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.311 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.25 -168.71 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.857 0.36 . . . . 0.0 111.162 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.794 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.0 OUTLIER -142.53 136.72 29.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.835 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.819 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -95.77 121.66 37.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.01 77.69 6.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.892 179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.58 HD23 HG22 ' A' ' 6' ' ' THR . 3.4 mm? -63.57 -41.14 98.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 6.9 t70 41.3 53.82 3.55 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.48 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -79.8 -37.46 35.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.28 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 77' ' ' LEU . 3.9 mp 62.17 17.72 9.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.764 -179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.72 33.79 0.14 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.687 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -60.44 -28.01 67.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.966 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 5.5 t-80 -81.68 175.05 10.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.841 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 24.0 t60 -100.33 83.57 2.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -160.96 134.79 6.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -70.48 176.41 4.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.861 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 24.0 p80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.918 -179.965 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 tpt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.845 0.355 . . . . 0.0 111.199 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 59.86 49.93 7.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 13.7 t30 -129.07 108.29 10.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.842 ' O ' HG22 ' A' ' 7' ' ' VAL . 2.6 m-20 -158.62 162.8 25.97 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.79 -22.98 26.62 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.593 2.195 . . . . 0.0 112.477 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.671 HG22 HD23 ' A' ' 74' ' ' LEU . 17.5 p -90.59 44.65 1.21 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.048 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.842 HG22 ' O ' ' A' ' 4' ' ' ASP . 6.8 m -146.72 173.22 2.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.258 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.814 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -148.75 136.25 20.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.571 179.889 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.854 ' NH1' HG13 ' A' ' 68' ' ' VAL . 5.4 mtt85 -147.6 144.64 28.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.407 ' HB2' HG21 ' A' ' 69' ' ' VAL . 22.7 t -68.62 142.52 94.14 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -74.27 -24.38 14.54 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.571 2.181 . . . . 0.0 112.323 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.8 p -152.68 -176.33 5.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.87 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.82 110.61 10.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.199 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.505 ' O ' HG23 ' A' ' 62' ' ' VAL . . . -130.99 -147.16 6.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.432 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 36' ' ' MET . 0.0 OUTLIER -162.25 137.29 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.636 0.255 . . . . 0.0 110.74 -179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.763 HD23 ' HA ' ' A' ' 59' ' ' PRO . 11.9 tp -67.59 97.29 0.59 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' C ' ' A' ' 35' ' ' GLU . 13.8 t -76.82 -38.35 54.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.062 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -166.98 -159.82 0.36 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.863 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -149.95 140.84 22.82 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.834 0.349 . . . . 0.0 110.818 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.1 p -95.4 -19.22 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.356 -179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 27.6 m -149.51 147.99 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.881 0.372 . . . . 0.0 111.406 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.07 -176.7 0.74 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.02 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -59.79 135.19 57.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.713 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.39 27.53 72.58 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.388 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.41 114.13 6.05 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.511 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 52' ' ' ARG . 14.1 p80 -62.41 120.63 11.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.012 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.727 HG22 HG23 ' A' ' 53' ' ' VAL . 34.2 m -146.66 136.04 16.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.333 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.68 163.61 19.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.766 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.793 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.78 125.76 9.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.398 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.21 -25.97 26.29 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.656 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -71.76 127.17 31.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.859 0.361 . . . . 0.0 110.849 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 2.6 p -67.02 137.33 56.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.985 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.599 ' HB3' HG21 ' A' ' 53' ' ' VAL . 32.2 p90 -113.14 -12.39 13.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.235 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.26 -174.47 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.767 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.488 ' C ' HG22 ' A' ' 17' ' ' THR . 8.1 mt-10 -145.65 152.24 39.34 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.879 -179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.536 ' HG2' HD11 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -150.87 124.36 8.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.729 179.7 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -89.63 163.28 15.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.936 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 39' ' ' MET . 1.5 t -144.95 173.28 4.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.612 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.567 ' H ' HG12 ' A' ' 38' ' ' VAL . 1.7 mtm -57.8 -30.54 65.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 110.76 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -77.74 -73.09 0.33 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.752 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 23.9 mmt -152.19 -178.14 6.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.841 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.476 HD11 HG21 ' A' ' 17' ' ' THR . 6.6 tp -82.07 149.78 4.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.736 179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.437 ' H ' HD12 ' A' ' 42' ' ' ILE . 19.3 mtp -142.43 155.75 45.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.223 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -119.71 131.16 55.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.93 -179.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD11 ' HG2' ' A' ' 36' ' ' MET . 1.1 mp -93.23 113.21 25.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.87 176.36 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.947 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.935 HG12 HD21 ' A' ' 72' ' ' LEU . 29.6 m -93.62 145.95 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.121 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 -85.49 -13.7 48.29 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.386 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.793 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 95.1 mt-10 -154.18 171.65 18.84 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.863 0.363 . . . . 0.0 110.938 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.583 ' O ' HD13 ' A' ' 74' ' ' LEU . 8.1 mpt_? -68.36 133.35 48.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.869 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 163.67 173.57 32.51 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.377 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HG2' ' HA ' ' A' ' 26' ' ' HIS . 12.0 mtt180 -93.63 129.5 39.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.004 0.43 . . . . 0.0 111.185 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.727 HG23 HG22 ' A' ' 27' ' ' VAL . 35.6 t -83.57 125.39 40.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.161 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' O ' ' CD1' ' A' ' 56' ' ' ILE . 19.1 mttt -116.48 107.8 15.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.555 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.607 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.0 m-85 -58.09 133.0 55.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.388 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.414 ' CD1' ' O ' ' A' ' 54' ' ' LYS . 1.5 mp -105.39 -59.63 3.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.372 179.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' N ' HG22 ' A' ' 56' ' ' ILE . 5.8 mmtt -72.02 172.14 10.6 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.863 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.7 164.42 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.816 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.763 ' HA ' HD23 ' A' ' 16' ' ' LEU . 36.5 Cg_endo -65.42 131.68 28.88 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.514 2.143 . . . . 0.0 112.178 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.92 -17.17 54.57 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.7 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.47 136.87 53.92 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.898 0.38 . . . . 0.0 111.392 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 14' ' ' GLY . 9.0 p -78.0 126.21 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.038 HD12 HG22 ' A' ' 69' ' ' VAL . 3.1 mm? -83.23 149.5 26.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.04 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mm-40 -124.59 159.46 30.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.774 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.46 87.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.043 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 122.11 -12.65 9.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.738 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -64.67 146.31 54.91 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.854 HG13 ' NH1' ' A' ' 9' ' ' ARG . 17.1 t -81.8 103.27 8.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.088 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.038 HG22 HD12 ' A' ' 63' ' ' LEU . 21.4 t -82.94 -25.77 8.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.595 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.31 -170.3 1.64 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.994 0.426 . . . . 0.0 111.743 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.482 ' CD ' HG12 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -143.21 137.3 28.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.591 179.945 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.935 HD21 HG12 ' A' ' 47' ' ' VAL . 0.5 OUTLIER -96.39 161.69 13.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 111.157 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -142.79 95.36 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.715 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.671 HD23 HG22 ' A' ' 6' ' ' THR . 4.4 mm? -62.47 115.43 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.124 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.92 65.36 1.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.713 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.6 p-10 -75.99 158.59 31.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.003 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.2 tp -85.66 -24.24 27.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.143 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -73.33 92.21 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.852 0.358 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' O ' ' CG ' ' A' ' 80' ' ' HIS . 5.8 p80 -111.59 -30.1 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.03 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . 0.433 ' CG ' ' O ' ' A' ' 79' ' ' HIS . 31.7 p80 44.87 44.45 7.84 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.418 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 36.6 m-70 -134.69 98.11 3.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 8.6 t-160 -100.09 87.95 3.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.942 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 48.2 t-80 -98.64 -24.13 15.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 58.7 m80 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.258 -0.877 . . . . 0.0 110.918 -179.997 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.8 mtt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.841 0.353 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -118.2 112.89 20.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.875 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -144.13 111.03 5.72 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -81.27 155.46 71.97 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.74 -24.76 54.34 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.517 2.145 . . . . 0.0 112.274 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.533 HG22 ' HB2' ' A' ' 74' ' ' LEU . 62.4 p -90.22 42.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.766 HG13 ' HD3' ' A' ' 71' ' ' ARG . 13.5 t -148.53 122.21 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.866 0.365 . . . . 0.0 111.01 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -88.79 140.41 29.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.844 179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.538 ' H ' HD13 ' A' ' 8' ' ' LEU . 43.9 mtt180 -150.22 136.3 18.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.4 144.71 96.78 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.979 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -73.65 -25.96 14.3 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.604 2.203 . . . . 0.0 112.29 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 83.1 p -152.75 179.83 8.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.836 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.96 115.03 15.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.138 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 63' ' ' LEU . . . -146.76 136.85 6.4 Favored Glycine 0 C--O 1.227 -0.321 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.275 179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' VAL . 1.7 tmmm? -75.69 139.47 41.95 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.846 0.355 . . . . 0.0 110.905 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.862 HD23 ' HA ' ' A' ' 59' ' ' PRO . 17.3 tp -66.63 95.27 0.33 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.671 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.457 HG21 HD11 ' A' ' 42' ' ' ILE . 13.4 t -75.36 -42.91 52.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.362 -179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.39 -162.78 0.54 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.752 0.31 . . . . 0.0 111.139 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -150.04 142.83 24.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.788 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.1 p -95.45 -12.87 25.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.459 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 26.9 m -149.69 142.49 17.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.894 0.378 . . . . 0.0 111.285 -179.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -68.14 -176.12 0.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.931 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.68 127.0 29.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.774 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.09 25.87 72.35 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.44 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -67.08 113.03 5.29 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.515 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 16.3 p80 -62.3 120.77 11.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.856 0.36 . . . . 0.0 111.025 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.662 HG22 HG23 ' A' ' 53' ' ' VAL . 35.6 m -145.53 138.39 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.068 179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.25 159.35 20.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.907 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.558 ' HB2' ' HA ' ' A' ' 49' ' ' GLU . . . -47.98 129.97 15.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.339 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.64 -25.84 24.58 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.551 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 43.4 t -71.75 130.72 41.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.809 0.338 . . . . 0.0 110.895 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 19.3 p -66.88 140.97 57.81 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 45' ' ' LEU . 30.4 p90 -120.56 -12.3 8.94 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.755 ' HB2' ' OH ' ' A' ' 55' ' ' TYR . . . -172.65 -172.75 0.92 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.861 0.363 . . . . 0.0 111.04 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' HG2' HG23 ' A' ' 44' ' ' THR . 7.8 mt-10 -147.7 164.75 32.58 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.763 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . 0.851 ' SD ' HD21 ' A' ' 45' ' ' LEU . 6.5 ptm -150.33 127.79 11.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.943 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -90.26 107.87 19.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.941 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.548 HG12 ' H ' ' A' ' 39' ' ' MET . 1.8 t -92.14 171.31 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.668 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.548 ' H ' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -58.32 -28.56 65.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.777 0.322 . . . . 0.0 110.772 -179.992 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -77.68 -73.71 0.29 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.826 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -151.76 -168.31 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.874 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.457 HD11 HG21 ' A' ' 17' ' ' THR . 6.8 tp -82.27 150.39 4.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.961 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.44 ' H ' HD12 ' A' ' 42' ' ' ILE . 6.9 mmt -144.53 153.44 41.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.011 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.473 HG23 ' HG2' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -119.52 131.5 55.57 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.905 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.851 HD21 ' SD ' ' A' ' 36' ' ' MET . 3.0 mm? -91.36 150.04 21.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.795 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -138.71 170.04 16.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.144 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.685 HG12 HD21 ' A' ' 72' ' ' LEU . 4.8 m -93.26 148.3 4.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.145 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -86.5 -14.09 44.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.362 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.558 ' HA ' ' HB2' ' A' ' 29' ' ' ALA . 50.0 mm-40 -153.91 164.84 37.73 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.877 0.37 . . . . 0.0 110.953 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.34 141.4 55.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.997 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 155.44 -178.73 31.9 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.592 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.1 mpp_? -94.6 121.03 35.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.827 0.346 . . . . 0.0 110.797 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.662 HG23 HG22 ' A' ' 27' ' ' VAL . 21.9 t -82.16 125.91 39.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -115.19 111.07 20.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.553 179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.755 ' OH ' ' HB2' ' A' ' 34' ' ' ALA . 3.1 m-85 -57.79 131.36 50.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.359 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.4 mp -105.63 -50.9 8.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.331 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.87 166.8 21.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.824 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -92.53 164.45 22.49 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . 0.862 ' HA ' HD23 ' A' ' 16' ' ' LEU . 38.1 Cg_endo -66.52 129.86 22.28 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.562 2.174 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 88.52 -17.96 45.5 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.744 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.74 137.52 54.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 0.0 111.509 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 15' ' ' LYS . 21.7 t -78.64 122.79 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.737 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.547 ' HB2' ' O ' ' A' ' 14' ' ' GLY . 5.5 mp -82.32 164.93 20.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.965 0.412 . . . . 0.0 110.891 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -134.0 158.78 42.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.811 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.29 87.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.969 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 123.44 -11.03 8.55 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.777 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' CYS . . . . . . . . . . . . . 44.9 t -64.87 146.69 54.56 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.825 0.345 . . . . 0.0 110.877 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 8' ' ' LEU . 21.5 t -81.38 106.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.149 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.439 ' CG2' HD23 ' A' ' 63' ' ' LEU . 21.3 t -82.25 -25.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.363 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -166.04 -166.02 0.87 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.167 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.766 ' HD3' HG13 ' A' ' 7' ' ' VAL . 0.3 OUTLIER -141.81 140.54 33.01 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.863 -179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.686 HD23 HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -95.98 121.96 38.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.946 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -90.17 77.62 6.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.922 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.533 ' HB2' HG22 ' A' ' 6' ' ' THR . 3.3 mp -63.68 124.77 22.28 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.803 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -73.02 63.04 0.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.025 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.39 170.62 16.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.869 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 91.1 mt 58.13 48.58 12.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.961 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -165.78 122.36 1.38 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.891 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 24.6 m-70 -141.65 152.33 43.84 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.812 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 -79.04 150.29 31.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -140.88 157.07 45.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.877 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -109.52 -30.52 7.89 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.961 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 p80 -63.08 -23.91 67.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.065 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.264 -0.874 . . . . 0.0 110.912 179.967 . . . . . . . . 0 0 . 1 stop_ save_